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Abstract 
The main topic of this work is detection of solid particles suspended in 
conductive medium and development of methodologies for determining 
cholesterol levels in human blood non-invasively by electrical impedance 
technique. 
The main part of this research is focused on the development of methodologies 
for numerical finite element (FE) modelling of simplified blood-cholesterol 
system, representing a real measurement system. This has been done first in 
2D, to prove the concept and then in 3D, to take into account all of the effects 
that would only be present in 3D system as well as taking into account that 
there is a fully 3D problem in the heart of presented research. The proposed 
model has been tested in various extreme cases and theoretical and some 
experimental validations have been carried out to establish a degree of 
confidence in the modelling methodologies developed. 
This included novel way of model simplification by introduction of particle 
coagulation. This method has been proven to be successful replacement of 
effective conductivity method, used in the past. It has been tested against 
variation in physiological parameters, such as particle concentration and 
distribution, and material properties, such as particle conductivities.    
In 3D modelling cases the red blood cells (RBC) have been added to further 
increase the complexity of the system. Several case studies were used to help 
analyse which physical parameters of RBC would have the biggest impact on 
system’s impedance. Results were validated against experimental data where 
possible. This allowed extension of proposed methodology to non-spherical 
particles modelling.  
The other methodology adopted in this work applies to the electrode modelling. 
All electrodes are modelled as hollows. This tactic has been proven to work. It 
Abstract 
 
xi 
 
was validated both theoretically and by comparing computational model results 
with experiment results (BERG, City University London).  
In Conclusions, it is discussed that both methodologies can be used outside of 
current research in electromagnetic simulations of less conductive particles in 
conductive solvent and in cases where electrode material is not known.  
Modelling investigations of the simplified blood-cholesterol systems using the 
2D and 3D FE modelling methodologies developed in this work have shown that 
it should be possible to measure cholesterol levels in human blood by 
impedance technique. Opinion sought from clinical staff highlight that this can 
potentially improve patient care by minimizing time needed for tests and human 
error (by shortening the number of people involved in testing). The work also 
establishes and discusses the need for further work, both theoretical and 
experimental for development of a measuring device for non-invasive 
measurement of cholesterol in human blood by impedance technique. 
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   Chapter 1. Introduction and background 
1.1 Introduction 
The word cholesterol came from the Greek words ‘chole’ (bile) and ‘stereos’ 
(solid), and the suffix ‘ol’ – from the word alcohol. It was first discovered in solid 
form in gallstones by the French researcher François Poulletier de la Salle in 
1769. Cholesterol (C27H46O), ‘the most highly decorated small molecule in 
biology’ is a lipid like, waxy alcohol, which is transported in the blood plasma of 
all animals. It is essential for cellular functions, production of hormones and it 
plays a key role in many biochemical processes. However, in the last few 
decades cholesterol has attracted wide publicity because of its association with 
cardiovascular diseases. While minimum levels of cholesterol are essential for 
life, high levels in the blood circulation are associated with atherosclerosis. 
Commonly referred to as a ‘hardening’ and ‘furring’ of the arteries, 
atherosclerosis is a disease of arterial blood vessels manifested in the formation 
of multiple plaques within the arteries. It is promoted by excessive low-density 
lipoproteins (proteins that carry cholesterol and triglycerides) circulating in the 
blood plasma. If not addressed, it can lead to myocardial infarction (commonly 
known as a heart attack), stroke or peripheral vascular disease. 
There are at present a large number of direct and indirect methods that are 
available in clinical and research laboratories for the quantitative measurement 
of cholesterol in blood: chemical, electrophoretic, enzymatic [1]–[3]. These 
measurements are being done increasingly frequently and often for prophylaxis 
and awareness against cardiovascular diseases. All these methods require a 
sample of the blood obtained from the body by an invasive procedure. The 
procedure may carry a risk of bruise, infection and/or haematoma. There are, 
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however, some indirect methods by which the level of total cholesterol can be 
estimated using bioelectrical impedance measurements carried out elsewhere 
in the body [4]. As these methods are indirect and based on inference of 
cholesterol level from statistical data obtained by multiple impedance 
measurements of substances other than blood, they are complicated, time 
consuming and often lack accuracy and reproducibility. 
Thus, there is a growing need to develop a simple, non-invasive method for 
measuring total blood cholesterol. It is proposed to do this by using an electrical 
impedance technique in which the conductivity distribution of objects (e.g. 
cholesterol particles carried by lipoproteins) within a test volume (e.g. blood 
plasma) is measured in the form of impedance (Z) or admittance (Y=1/Z) by 
measuring the voltage (V) induced on electrodes attached to the surface when 
a small current (I) is passed between them. For example, in a tetrapolar 
impedance measurement the impedance is obtained by measuring the voltage 
drop between a pair of suitably placed electrodes (measuring or passive 
electrodes) when a small current flows between two separate driving or active 
electrodes placed on the body surface (Z=V/I). For cholesterol measurement, 
the measured impedance is a function, among others factors of the size, 
concentration and distribution of lipoproteins carrying cholesterol particles.  
The electrical impedance technique has been used successfully for many 
biological measurements, especially for measuring characteristics of blood. 
These include measurement of body fluid volume [5], fat [6], [7], glucose[8]–
[10], blood coagulation [11], haematocrit (erythrocyte volume fraction, EVF) 
[12], white blood cell count and other blood measurements [13]. All these blood 
measurement methods involve an invasive procedure for obtaining blood from 
the body.  
As mentioned earlier, in the impedance technique the conductivity distribution of 
objects (e.g. cholesterol particles carried by lipoproteins) within a test volume 
(e.g. blood plasma) is measured in the form of impedance by measuring the 
voltage induced on electrodes attached to the surface. The impedance is 
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calculated from measured voltage and current (Z=V/I). The mathematical 
modelling of the living tissue can theoretically establish the feasibility of the 
impedance technique for direct, non-invasive measurement of cholesterol level 
in the blood. One of the main challenges is to establish by simulation various 
design parameters of the measurement circuit (electrode material, size, shape, 
number, alignment and placement, current level, frequency, etc.) that ensures 
adequate distribution of current (electric field) and an induced electric potential 
between electrodes. Although the mathematical physics of conduction is well 
understood, the mathematics of describing the current and potential fields 
between and around impedance electrodes, particularly those attached to 
tissue, is more challenging (e.g. skin-electrode impedance, capacitance effect 
of skin, skin layers - epidermal, dermal, subcutaneous layers, etc.).  
Finite element (FE) models are used to investigate the effects of various 
parameters on the distribution of alternating currents and electric potential 
(hence voltage drops) in the problem domain. These parameters include 
various physiological (e.g. level and distribution of lipoproteins, other blood 
components), material (e.g. dielectric permittivities and conductivities of blood 
components) and electrical variables (e.g. measurement circuitry, excitation 
frequency, electrode geometry and their placement). Since the unknown 
potential distribution is a function of many of the physiological components in 
blood and tissue, the modelling challenge here is to, by simulation, establish an 
adequate and identifiable functional relationship between this distribution and 
the level of cholesterol in the blood.  
By advanced biomedical signal analyses the impedance data obtained in the 
methods outlined above from FE simulation and from subsequent investigation 
conducted on experimental prototypes discussed below, it should be possible to 
establish a functional relationship between calculated voltage drops across 
measuring electrodes (hence impedance values) and concentration of 
lipoproteins in the blood. 
This leads to the main aims and objectives of the research.  
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1.2 Aims and Objectives 
Considering the above, the main aims and objectives of the proposed research 
were formulated: 
Aim 1 Justify necessity of new method for cholesterol level measurement. This 
will be done by: 
a) Analysis of all existing methods, including highlighting their 
advantages and disadvantages 
b) In depth understanding of current routine test process   
c) Sought clinician’s opinion on proposed method 
Aim 2 Development of appropriate methodologies for mathematical modelling 
and simulation of penetration of electric field and distribution of electric 
current and potential in living tissues. This leads to further objectives: 
a) Develop 2D realistic finite element (FE) models 
b) Develop 3D realistic finite element (FE) models   
Aim 3      Investigate the distribution of alternating currents and electric 
potential in developed FE models. This will be achieved through the 
following objectives:  
a) Use various physiological properties (e.g. level and distribution of 
lipoproteins, other blood components) in FE models developed in 
Aim1 (a) and Aim1 (b) 
b) Change of material  properties (e.g. dielectric permittivities and 
conductivities of blood components including lipoproteins carrying 
cholesterol particles)  
c) Change of electrical parameters (e.g. measurement circuitry, 
excitation frequency, electrode geometry and their placement) 
Aim 4     Establish functional relationship between calculated currents on 
measuring electrodes (hence impedance values) and concentration of 
cholesterol in the blood. Objective related to this aim is:   
a) For a given voltage drop, this is done by advanced biomedical signal 
processing of potential signals calculated by FE modelling. 
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1.3 Background 
1.3.1 Cholesterol in body 
Role and function 
Cholesterol (see Figure 1.3–1 for chemical structure) is a waxy steroid, which is 
synthesized in many types of tissue, but particularly in liver and intestinal wall. It 
is used for hormone and cell membrane production and is transported in the 
blood plasma [14]. It is an essential structural component of cell membranes. 
One of its functions is to establish proper membrane permeability and fluidity. It 
also is one of the key components for production of bile acids, steroid 
hormones, and Vitamin D. On one hand small quantities of cholesterol are 
important and necessary,  on the other hand high levels of cholesterol can 
damage arteries and are potentially linked to diseases such as those associated 
with the cardiovascular system (heart disease) [15].  At the end of its life cycle 
cholesterol is recycled; excreted by the liver into the digestive tract. Typically 
about 50% of the excreted cholesterol is reabsorbed by the small bowel back 
into the bloodstream [16].  
 
Figure 1.3–1. Chemical structure of cholesterol 
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Cholesterol is a unique building block for membranes; it also influences 
membrane fluidity. Cholesterol’s hydroxyl group interacts with the polar head 
groups of the membrane phospholipids, while the steroid and the hydrocarbon 
chain are sitting  inside the membrane. Basically cholesterol reduces the 
permeability of the plasma membrane to protons (positive hydrogen ions) and 
sodium ions [17]. Figure 1.3–2  illustrates this mechanism. 
 
Figure 1.3–2. Plasma membrane 
 
Within the cell membrane, cholesterol also functions in intracellular transport, 
cell signalling and nerve conduction. Recently, cholesterol has also been 
implicated in cell signalling processes, assisting in the formation of lipid rafts in 
the plasma membrane. For example, a myelin sheath, rich in cholesterol, in 
neurons provides insulation for more efficient impulse conduction [18].  
Cholesterol is also known as a predecessor in several biochemical processes. It 
is converted to bile in liver, which is then stored in the gallbladder. Bile salts are 
initial component in the intestinal absorption of fat molecules as well as the fat-
soluble vitamins, such as Vitamin A,  D, E and K. Which makes cholesterol is an 
important precursor molecule for the synthesis of Vitamin D and the steroid 
hormones (including cortisol, aldosterone, progesterone, oestrogens, and 
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testosterone, and their derivatives). Some research indicates that cholesterol 
may act as an antioxidant [19]. Moreover, in its unoxidized form it eliminates risk  
of  diseases induced by free-radicals and cancer, by functioning as a membrane 
protector [20]. 
Sources 
Food 
Approximately three quarters of cholesterol is newly synthesized and a quarter 
originates from dietary intake. Animal fats are complex mixtures of triglycerides, 
with phospholipids and cholesterol. This means that all foods containing animal 
fat contain cholesterol [21]. Major cholesterol sources are cheese, egg yolks, 
beef, pork, poultry, and shrimp [22]. Human breast milk also contains significant 
quantities of cholesterol [23].  
The amount of cholesterol present in plant-based food sources is generally 
much lower than animal based sources [22], [24]. Total fat intake, especially 
saturated fat and trans fat [25], plays a larger role in blood cholesterol than 
direct cholesterol intake. Sources of saturated fat are full fat dairy products, 
animal fats, some types of oil and chocolate. Trans fats are found in the partial 
hydrogenation of unsaturated fats. Products having trans fat are margarine and 
hydrogenated vegetable fat, as well as fast foods, packed snacks, fried and 
baked goods. 
It is believed that a change in dietary fat and cholesterol intake can lower blood 
cholesterol levels [15], (and thus reduce the likelihood of development of 
coronary artery disease). But results are equivocal as there were experiments 
showing that  reduction of dietary cholesterol intake is counteracted by the 
organs trying to compensate it and trying to keep blood cholesterol levels 
constant [26]. Also it was shown that  ingested animal protein can raise blood 
cholesterol more than the ingested saturated fat or any cholesterol [27]. 
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Body synthesis 
Animal cells can produce cholesterol; the amount of it depends on cell type and 
function. About 20–25% of total daily cholesterol production occurs in the liver; 
other sources of synthesized cholesterol include the intestines, adrenal glands, 
as well as reproductive organs. For cholesterol synthesis one molecule of acetyl 
CoA and one molecule of acetoacetyl-CoA are needed. As a result of a chain of 
chemical reactions with enzymes, reactions with presents of adenosine-5'-
triphosphate (ATP) lanosterol is produced, which is then converted into 
cholesterol [28]. 
Biosynthesis of cholesterol is directly regulated by the cholesterol levels 
present. A higher intake from food decreases its endogenous production, lower 
intake from food leads to opposite. The main regulatory mechanism is the 
registration of intracellular cholesterol in the endoplasmic reticulum by the 
protein SREBP (sterol regulatory element-binding protein 1 and 2) [29]. In the 
presence of cholesterol, it is bound to two other proteins: SCAP (SREBP 
cleavage activating protein) and Insig-1. When cholesterol levels fall, second 
one dissociates from the complex SREBP-SCAP, allowing the complex to 
migrate to the Golgi apparatus, leading to a chain of reactions that stimulates 
the transcription of many genes. Among these is the low-density lipoprotein 
(LDL) receptor. The former scavenges circulating LDL from the bloodstream, 
whereas there are other processes leading to an increase of endogenous 
production of cholesterol [30].  
Cholesterol synthesis can be turned off when cholesterol levels are high, as 
well. Increasing concentrations of cholesterol (and other sterols) cause some 
changes, which makes it more susceptible to destruction by the proteosome, 
which activity can also be reduced by phosphorylation by an AMP-activated 
protein kinase. Because this last one is activated by adenosine monophosphate 
(AMP), which is produced when ATP is hydrolysed, it follows that cholesterol 
synthesis is halted when ATP levels are low [31].  
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Transportation  
Cholesterol is almost insoluble in water (0.095 mg/L at 30 °C) and that is why it 
can dissolve and travel in the water-based bloodstream at exceedingly small 
concentrations. This property also leads to the fact that it is transported in the 
blood stream by means of bigger particles called lipoproteins, which are 
complex particles that have an exterior composed of amphiphilic proteins and 
lipids whose outward-facing surfaces are water-soluble and inward-facing 
surfaces are lipid-soluble; triglycerides and cholesterol esters are carried inside. 
Phospholipids and cholesterol, being amphipathic, are placed in the surface 
monolayer of the lipoprotein (Figure 1.3–3). 
 
Figure 1.3–3. Structure of lipoprotein 
 
In addition to that, lipoproteins have their own ‘signature’ in a form of 
apolipoprotein that direct the lipids they carry to certain tissues. Because of that, 
there are several types of lipoproteins within blood called, in order of increasing 
density and decreasing size, very low density lipoprotein (VLDL), intermediate 
density lipoprotein (IDL), low density lipoprotein (LDL) and high density 
lipoprotein (HDL) (Table 1-1). 
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Table 1.1.Types of lipoprotein 
Lipoprotein type Diameter, nm Density, g/ml Cholesterol/triglycerides 
chylomicrons 100-1000 <0.95 8%/84% 
VLDL 30-80 0.95-1.006 22%/50% 
IDL 25-50 1.006-1.019 29%/31% 
LDL 18-28 1.019-1.063 50%/4% 
HDL 5 - 15 >1.063 20%/8% 
 
The density of lipoprotein depends on cholesterol/protein concentration. The 
more cholesterol/less protein there is the lower its density is. The cholesterol 
within all types of lipoproteins is identical, although some of it is carried as the 
‘free’ alcohol and some as fatty acyl esters called cholesterol esters. However, 
the different apolipoproteins, which serve as markers for cell membrane 
receptors, determine the start- and endpoints for cholesterol transport (Figure 
1.3–4). 
 
Figure 1.3–4. Classification of lipoproteins 
Chylomicrons, the least dense type of cholesterol carrying molecules, contain 
apolipoprotein B-48, apolipoprotein C, and apolipoprotein E. They transport fats 
from the intestine to muscle and other tissues that need fatty acids to produce 
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energy or fat. Chylomicron remnants are taken up from the bloodstream by the 
liver and are cholesterol-rich because of not used cholesterol. 
VLDL are produced by the liver and contain excess triacylglycerol and 
cholesterol. They have apolipoprotein B100 and apolipoprotein E in their shells. 
During transport in the bloodstream, triacylglycerol is partially absorbed from 
IDL molecules, which leads to even higher percentage of cholesterol. The IDL 
molecules are either taken up by the LDL receptor on the liver cell surfaces or 
continue to lose triacylglycerols in the bloodstream until they become LDL 
molecules, having the highest percentage of cholesterol present within. 
This means that LDL molecules are the major carriers of cholesterol in the 
blood. Each molecule of LDL has about 1,500 molecules of cholesterol ester. 
Apolipoprotein B100 set on a shell of LDL molecule is recognized by the LDL 
receptor in tissues. Once it happens many LDL receptors become trapped and 
after several chemo-physical processes its cholesterol is hydrolyzed (becoming 
cholesterol esters). After that cholesterol can be used within the cell for 
membrane biosynthesis or esterified and stored within the cell. 
Synthesis of the LDL receptor and control of cholesterol synthesis in response 
to its presence in the cell are regulated by the same protein. When the cell has 
more cholesterol then needed, LDL receptor synthesis is blocked so that no 
more cholesterol (LDL molecules) can get in. In the opposite case, more LDL 
receptors are made when the cell has lack of cholesterol [32]. When this system 
is not balanced, there will be LDL molecules in the blood having no receptors. 
They are oxidized and taken up by macrophages, which become foam cells. 
They can then get trapped in blood vessel walls and contribute to 
atherosclerotic plaque formation. Differences in cholesterol homeostasis effects 
the development of early atherosclerosis (carotid intima-media thickness) [33]. 
This is known to lead to heart attack, stroke, and other medical problems. That 
is why LDL cholesterol is often referred being a ‘bad’ cholesterol [31]. 
HDL particles are thought to play a key port in transporting  cholesterol back to 
the liver for excretion or to other tissues that use cholesterol to synthesize 
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hormones in a process known as reverse cholesterol transport (RCT) [34]. 
Having large numbers of large HDL particles correlates with better health 
outcomes [35]. In contrast, having small numbers of large HDL particles is 
independently associated with atheromatous disease progression within the 
arteries. 
Metabolism, recycling and excretion 
Liver oxidizes cholesterol into different bile acids [36]. These in turn are 
conjugated with glycine, taurine, glucuronic acid and sulphates. A mixture of bile 
acids, including cholesterol, is excreted into the bile from the liver. 
Approximately 95% of the bile acids are reabsorbed from the intestines and the 
remainder are lost in the faeces [37]. The excretion and reabsorption of bile 
plays a major part in the digestion and absorption of dietary fats. In some 
situations, in places with higher concentration e.g. the gallbladder, cholesterol 
crystallises and is the major constituent of most gallstones [38]. Cholesterol is 
mainly converted into coprostanol, a non-absorbable sterol which is excreted in 
the faeces [39].  
Cholesterol disorders 
Hypercholesterolaemia 
Having high concentrations of LDL in combination with low concentrations of 
functional HDL (hypercholesterolaemia) are strongly associated with 
cardiovascular disease because these causes development of atheroma in 
arteries (atherosclerosis). This leads to myocardial infarction (heart attack), 
stroke, as well as peripheral vascular disease. Because higher LDL particle 
concentrations and its smaller size, contribute to this process more than the 
cholesterol content of the HDL particles [40], LDL is often called ‘bad 
cholesterol’. On the other hand, if concentrations of functional HDL, which is 
responsible for cholesterol removal from cells and atheroma, are high, this is 
termed to as ‘good cholesterol’. The balance of these two is determined 
genetically but changes can be made by medications, food choices, and other 
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factors [41]. Increased levels of the lipoprotein fractions as well as LDL, IDL and 
VLDL are called atherogenic (‘helping’ to develop atherosclerosis) [42]. These 
fractions, and not the total cholesterol level, are known to correlate with the 
extent and progress of atherosclerosis. That means that although the total 
cholesterol can be within normal limits, if it is made up mostly of small LDL and 
small HDL particles, the atheroma growth rates would be high. But if LDL 
particle number is low and a large portion of the HDL particles are large, then 
atheroma growth rates are low for any given total cholesterol concentration [43]. 
In case of increased cholesterol levels a strict diet (low-saturated fat, trans-fat 
free) is recommended as well as low cholesterol foods [44], [45],  and is often 
followed by one of various hypolipidaemic agents, cholesterol absorption 
inhibitors, nicotinic acid derivatives or bile acid sequestrates [46]. Extreme 
cases of atheroma have previously been treated by means of partial ileal 
bypass surgery, which has now been replaced by medication. Although the role 
of cholesterol in cardiovascular disease is well known, some studies have 
suggested an inverse correlation between cholesterol levels and mortality. One 
of them, performed in 2009, shows that for  patients with acute coronary 
syndromes there is an association of hypercholesterolemia with better mortality 
outcomes [47].  
Hypocholesterolemia 
Abnormally low levels of cholesterol are known as hypocholesterolemia. Some 
studies suggest that this condition has a link with depression, cancer, and 
cerebral haemorrhage. In general, the low cholesterol levels seem to be a 
consequence of an underlying illness, rather than a cause [48]. 
1.3.2 Methods used for determination of cholesterol levels 
There is a whole variety of methods is available to determine serum cholesterol, 
such as ultracentrifugation, electrophoresis, high-performance liquid 
chromatography (HPLC), precipitation-based methods and direct methods.  The 
direct methods are used routinely. The most common method for determination 
of Total, HDL- , LDL- cholesterol and triglycerides nowadays is enzymatic 
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colorimetric test.  It is an automated method for direct determination of 
cholesterol in serum and plasma. There were also some attempts to perform 
non-invasive cholesterol measurements. The short review of those methods is 
given below. 
Invasive methods 
Reference method 
There is a reference method for cholesterol measurements. The process starts 
with serum cholesterol esters being hydrolysed by alcoholic KOH (potassium 
hydroxide). Then cholesterol is extracted by hexane, and is dried. After the dry 
residue is treated with acetic acid, acetic acid anhydride, and sulphuric acid 
(Liebermann-Burchard reagent), that develops a colour reaction that is 
measured at 620 nm. This method has minimum positive bias compared with 
the definitive method for cholesterol, which is mass spectrometry [49]. The 
results can be presented either in molar ci or mass concentration ρi: 
ρi (mg/dL) = 38.7* ci (mmol/L) (1.3-1) 
 
 
This method is very accurate, but its downside is that it is time-consuming and 
not suitable for automation. For routine screenings enzymatic methods have 
been developed.  
 
Ultracentrifugation 
The ultracentrifugation is a method used in biochemistry for determination of 
blood/serum/plasma components and their analysis. The ultracentrifuge is 
optimized for spinning a rotor at very high speeds, generating an acceleration 
as high as 1,000,000 g (9,800 km/s²). The two major kinds of ultracentrifuges 
are preparative and analytical. Both classes of instruments find important uses 
in molecular biology, biochemistry and polymer science. In analytical type of 
ultracentrifuge operator can observe a sample that is being spun in real time 
Introduction and background 
 
15 
 
through an optical detection system. The phenomena being monitored is 
ultraviolet light absorption and/or interference optical refractive index. The 
operator can see sample concentration evolution the axis of rotation profile as a 
result of the applied centrifugal field. Then the observed data are digitalized and 
stored for further analysis. 
The aim of the process is to distinguish between the shape and molar mass of 
different   macromolecules dissolved in analysed solution [50]. 
The huge rotational kinetic energy of the rotor in an operating ultracentrifuge 
makes the failure of a spinning rotor a serious concern. As the analyser is being 
used under stress of routine and is exposed to chemical solutions, its rotor can 
deteriorate with time. Proper use of the instrument and rotors within 
recommended limits and careful maintenance of rotors to prevent corrosion and 
to detect deterioration is necessary to avoid this hazard. In addition, maximum 
capacity is six samples, which in a hospital setting is not enough. For total 
cholesterol, one needs just one rotating cycle, for HDL/LDL separation 2 or 
more. 
Enzymatic colorimetric test 
The whole process starts when blood is withdrawn from a patient. It is put in a 
labelled sample holder and transferred from laboratory to biochemistry lab. 
Then on the first stage the blood is centrifuged adding a buffer solution, as a 
result blood plasma is separated from the blood cells. The blood plasma then is 
placed in a different holder and put into automated clinical chemistry analyser.  
There the chain of chemical reactions takes place with different reagents and 
catalysts.    
For cost reasons, LDL values have long been estimated using the Friedewald 
formula (or a variant):   
TC [total cholesterol] −HDL [total HDL] – 0.2TG [20% of the triglyceride value] = 
estimated LDL.  
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The main idea is that TC is defined as the sum of HDL, LDL, and VLDL. Usually 
just the total, HDL, and triglycerides are measured. The VLDL is calculated as 
one-fifth of the triglycerides. 
Below, there is a list of chemical reactions to obtain TC. ܿℎ݋݈݁ݏݐ݁ݎ݋݈ ݁ݏݐ݁ݎݏ + ܪଶܱ ௖ℎ௢௟௘௦௧௘௥௢௟ ௘௦௧௘௥௔௦௘→                ܿℎ݋݈݁ݏݐ݁ݎ݋݈ + ܴܥܱܱܪ (1.3-2) ܿℎ݋݈݁ݏݐ݁ݎ݋݈ + ܱଶ ௖ℎ௢௟௘௦௧௘௥௢௟ ௢௫௜ௗ௔௦௘→               ܿℎ݋݈݁ݏݐ­Ͷ­݁݊­͵­݋݊݁ + ܪଶܱଶ (1.3-3) 
 
 
The hydrogen peroxide created forms a red dyestuff by reacting with 4-
aminophenazone and phenol under the catalytic action of peroxidase. The 
colour intensity is directly proportional to the concentration of cholesterol and 
can be determined photometrically [51]. 
For HDL-cholesterol direct method with PEG-modified enzymes is used [52]:  ܪܦܮ­ܿℎ݋݈݁ݏݐ݁ݎ݋݈ ݁ݏݐ݁ݎݏ + ܪଶܱ ௉ா�­௖ℎ௢௟௘௦௧௘௥௢௟ ௘௦௧௘௥௔௦௘→                   ܪܦܮ­ܿℎ݋݈݁ݏݐ݁ݎ݋݈+ ܴܥܱܱܪ (1.3-4) 
ܪܦܮ­ܿℎ݋݈݁ݏݐ݁ݎ݋݈ + ܱଶ ௉ா�­௖ℎ௢௟௘௦௧௘௥௢௟ ௢௫௜ௗ௔௦௘→                  ∆ସ­ܿℎ݋݈݁ݏݐ݁݊݋݊݁ + ܪଶܱଶ (1.3-5) ʹܪଶܱଶ + Ͷ­ܽ݉݅݊݋­ܽ݊ݐ݅݌ݕݎ݅݊݁ + ܪܵܦ� + ܪ+ + ܪଶܱ௣௘௥௢௫௜ௗ௔௦௘→        ݌ݑݎ݌݈݁­ܾ݈ݑ݁ ݌݅݃݉݁݊ݐ + ͷܪଶܱ (1.3-6) 
 
 
The method used for determination of triglycerides is based on work by 
Wahlefeld getting a lipoprotein lipase from microorganisms for the rapid and 
complete hydrolysis of triglycerides to glycerol that is then oxidised to 
dihydroxyacetone phosphate and hydrogen peroxide. This product then reacts 
with 4-aminophenazone and 4-chlorophenol under the catalytic action of 
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peroxidase to form a red dyestuff (Trinder endpoint reaction). The colour 
intensity is directly proportional to the triglyceride concentration [53]. 
ݐݎ݈݅݃ݕܿ݁ݎ݅݀݁ݏ + ͵ܪଶܱ ௅௉௅→ ݈݃ݕܿ݁ݎ݋݈ + ͵ܴܥܱܱܪ (1.3-7) 
݈݃ݕܿ݁ݎ݋݈ + �ܶܲ �௄,ெ௚మ+→      ݈݃ݕܿ݁ݎ݋݈­͵­݌ℎ݋ݏ݌ℎܽݐ݁ + �ܦܲ (1.3-8) 
݈݃ݕܿ݁ݎ݋݈­͵­݌ℎ݋ݏ݌ℎܽݐ݁ + ܱଶ �௉ை→  dihydroxyacetone phosphate + ܪଶܱଶ (1.3-9) ܪଶܱଶ + Ͷ­aminophenazone +  Ͷ­chlorophenol ௣௘௥௢௫௜ௗ௔௦௘→           (1.3-10) Ͷ­ሺp­benzoquinone­monoiminoሻ­phenazone + ʹܪଶܱ + ܪܥ݈  
 
 
On average these tests take about 10-15 minutes each, but there is a lot of 
room for human factor errors (such as labelling and transferring of the blood 
samples to the lab, changing the samples and getting correct results in the 
relevant files). Serum cholesterol tests are not the first priority in the 
biochemistry lab, which is why it takes up to one week to get the results of the 
test (information obtained from Biochemistry lab, Whittington Health, London). 
Electrophoresis 
Electrophoresis (cataphoresis) is the motion of charged particles in a solid or 
liquid matrix under the influence of an electric field [54], [55]. For this type of 
analysis blood plasma samples are used. Rate of movement for particles in 
suspension depends on its mass and size: larger particles move slower 
because of friction and highly charged particles move quicker. Lipoproteins are 
separated through a gel matrix with varying pore size, for that purpose 
polyacrylamide is commonly used. Those gels can be cast as columns or slabs. 
For analysis slabs are widely used, because it allows the separation and 
comparison of multiple samples. A ‘stacking’ gel is placed on the top of the 
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separating (‘running’) gel to sharpen the bands before they enter the gel (Figure 
1.3–5). 
 
 
Figure 1.3–5. Electrophoresis set 
 
The electrophoresis buffer and the buffer in the separating gel have a high pH 
(8.9) and contain glycine. In contrast, the stacking gel buffer has a low pH (6.8) 
and contains Cl-. At the low pH of the stacking gel, the Cl- ions in the stacking 
gel are negatively charged and start moving towards the anode, but the glycine 
entering from the gel buffer has only a very small negative charge. Because Cl- 
moves faster than glycinate, a low conductivity zone within the gel is formed. 
Higher electric field appears and accelerates the proteins so that they come to 
the separating gel as a narrow band at the boundary between the leading Cl- 
and the trailing glycinate ions. The glycine becomes completely dissociated 
once the protein complexes reach the running gel, and it migrates at the same 
speed as Cl-. For visible results the membrane is stained. After electrophoresis 
the cellulose acetate strips are stained overnight at room temperature and then 
rinsed in solution containing industrial spirit, water and glacial acetic acid. 
Colour and intensity of the stripes obtained are analysed [56]. 
This method is one of the oldest used for lipoprotein separation and one of the 
most reliable but it is time-consuming and not suitable for automation. There is 
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also plenty of room for human mistakes as any changes in sample preparation 
can lead to the sample being destroyed.  
High-Performance Liquid Chromatography 
The main principle of high-performance liquid chromatography (HPLC) is that 
solution moved through the column is slowed by specific chemical or physical 
interactions with the stationary phase present within the column. The velocity of 
this solution movement depends on the nature of the sample and on the 
compositions of the stationary (column) phase. The time at which a specific 
sample comes out of the end of the column is called the retention time; the 
retention time under particular conditions is considered an identifying 
characteristic of a given sample. 
The analysed sample is put, in small volumes, into the stream of mobile phase. 
Lipoprotein samples are isolated by ultracentrifugation and separated by 
chromatography on Bio-Gel agarose. Total lipid extracts of the lipoprotein 
samples are prepared by extraction with chloroform-methanol. Cholesteryl 
heptadecanoate added to aliquots of lipoprotein total lipid extracts. The 
lipoprotein extracts are prepared for HPLC analysis by evaporating the 
extraction solvent and re-dissolving the lipid in tetrahydrofuran-acetonitrile. This 
volume is injected into the liquid chromatograph.  Cholesterol and cholesteryl 
esters are eluted from the column using a linear water gradient. The water 
concentration in acetonitrile-tetrahydrofuran is reduced from 3% to 0% over a 
20-min period at 37°C with a solvent flow rate of 2.0 ml/min. Cholesterol and 
cholesteryl esters eluting from the column are detected by their ultraviolet 
absorption at 123 nm [57]. The mass of cholesterol are calculated from 
standard curves of mass versus peak area by the following formula: 
ܵܽ݉݌݈݁ ݉ܽݏݏ = (ܯܽݏݏ ݋݂ ݏݐܽ݊݀ܽݎ݀ܲ݁ܽ݇ ݋݂ ݏݐܽ݊݀ܽݎ݀ × ܲ݁ܽ݇ ܽݎ݁ܽ ݋݂ ݏݐܽ݊݀ܽݎ݀) ÷ (1.3-11) ÷ ሺ% ܴ݁ܿ݋ݒ݁ݎݕ ݋݂ ݏݐܽ݊݀ܽݎ݀ሻ/ͳͲͲ 
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Reversed phase columns are quite difficult to damage compared with normal 
silica columns. They can be used with aqueous acid, but the column should not 
be in contact with the acid for too long, as it can damage the metal parts of the 
HPLC equipment. The metal content of columns must be kept low if the best 
possible ability to separate substances is to be retained. The main down side of 
this method is that there is a need for ultracentrifugation prior to 
chromatographic analysis.  
Accutrend® Plus Dual Testing System 
The lipoprotein complexes are dissolved by the detergent DONS so that the 
cholesterol esterase can split the cholesterol ester into cholesterol and the 
corresponding fatty acid. Cholesterol then is oxidized to 4-cholesten-3-one plus 
H2O2 by cholesterol oxidase. The hydrogen peroxide converts an indicator dye 
(TMB) to a blue colour by means of peroxidase [58].  
On a plus side  this system is portable and gives results within minutes. 
But  test strips have to be stored in tight capped vial, they have expiration date 
and the test result coming out on the screen as either high or low (higher than 
7.76 mmol/L or lower than 3.88 mmol/L).  
Non-invasive methods 
Classification of Total Cholesterol Level Using Bioelectrical Impedance 
A rule based expert system has been developed for total cholesterol (TC) level 
classification using bioelectrical impedance analysis (BIA). Parameters that are 
being used as predictors are body capacitance (BC), basal metabolic rate 
(BMR), extracellular mass (ECM), and lean body mass (LBM). This method can 
classify subjects’ TC level between normal (<= 5.2 mmol/L) and abnormal (>5.2 
mmol/L).  
The first tests show that the system total accuracy for classifying TC level at 0.6 
probability cut-off prediction was only 70%. The sensitivity was 67%, and 
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specificity of 74%. From the validation data, this system can classify 6 from 10 
subjects correctly [59]. 
PreVu Non-Invasive Cholesterol Test 
This method is used to predict skin cholesterol levels. Skin cholesterol does not 
correlate with those of serum, but have been proven to give valid prediction of 
coronary artery disease (CAD) possibility. A foam pad with 3 wells is placed on 
the palm of the patient’s hand and adheres with special medical adhesive 
(Figure 1.3–6). Then a drop of detector solution is added. A one minute wait is 
needs for the co-polymer (Digitonin & HRP) to bond with skin cholesterol. A 
drop of indicator solution (TMB) is added. Cholesterol changes solution colour 
in the foam pad well. After a two minute wait the resulting blue colour can be 
read and quantified using handheld spectrophotometer. This is then translated 
into a risk number [60], [61]. 
 
Figure 1.3–6. PreVu test performance 
 
Even though this method is non-invasive and does give information on 
cholesterol level and CAD possibility, there is no link between those levels and 
cholesterol levels measured during routine screening. This does not create any 
difficulties in case of low cholesterol levels. For increased cholesterol levels 
dosage of statins is directly linked to blood cholesterol levels. Which means that 
there is a need for regular blood test.  
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1.3.3 Proposed Non-Invasive Impedance Method 
The review of all existing methods (Table 1-2) shows that there is an urgent 
need for creation of portable non-invasive speedy reliable method that 
measures some parameter strongly linked with serum cholesterol levels. It will 
be proven in the presented research that impedance of blood is such quantity. 
Table 1.2. Cholesterol measurements methods 
 Method Principle Advantages Disadvantages 
Invasive Reference 
method 
Chain of 
chemical 
reactions 
followed by 
colour intensity 
measurement 
Very 
accurate 
Time-consuming,  
not suitable for 
automation 
Ultracentrifugation Ultraviolet light 
absorption test 
after high-
speed 
centrifugation 
Accurate Low capacity, 
time-consuming 
Enzymatic 
colorimetric test 
Chain of 
chemical 
reactions 
followed by 
colour intensity 
measurement 
Accurate Is a low priority 
test performed in 
hospitals 
Electrophoresis Electrophoretic 
separation 
followed by 
Reliable, 
accurate 
Time-consuming,  
not suitable for 
automation 
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product 
staining and 
colour intensity 
analysis 
HPLC Lipoproteins 
are separated 
in accordance 
with their 
mass, then 
ultraviolet 
absorption 
measured  
Reliable Needs 
ultracentrifugation 
prior to 
chromatography 
Accutrend Plus Chemical 
reaction 
producing 
colour on a test 
strip 
Portable 
system, quick 
results  
Indicates 
cholesterol level 
as “high” or “low” 
Non-
invasive 
Classification BIA Rule based 
system 
Non-invasive Low accuracy 
PreVu  Chemical 
reaction results 
are measured 
with portable 
spectrometer 
Non-invasive Measured 
cholesterol levels 
do not correlate 
with serum 
cholesterol 
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   Chapter 2. Mathematical Modelling of 
Electromagnetic Field Distribution in 
Conductive Suspension 
2.1 Introduction 
This chapter reviews finite element method and mathematical formulation of 
electric field distribution in 2D/3D model. The aim is to discuss direct current 
(DC) and high-frequency cases and explain the way they are simulated. 
Non-invasive electrical measurement of cholesterol is an alternative to existing 
methods for determination of cholesterol levels. The suggested method is 
based on impedance measurement.  To find the impedance of a biological 
object one needs to know current flowing through it. And to find current it is 
necessary to know field and its distribution inside the object being studied. For 
better problem understanding and setting up a correct mathematical model of a 
set-up its physics background needs to be reviewed. 
For 2D modelling COMSOL 4.0 has been used on a machine with Intel Core 2 
duo CPU GHz, 4GHz RAM, 64-bit operating system. 
For 3D modelling COMSOL 4.2 has been used on a machine with Intel Xeon 
CPU 3.1Ghz processor, 16GB RAM, 64-bit operating system and Intel Xeon 
CPU 3.6Ghz processor, 32GB RAM, 64-bit operating system. 
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2.2 Mathematical formulation of electric field 
distribution in conductive suspension 
2.2.1 Maxwell’s equations 
All electromagnetic problems are described by four basic Maxwell’s equations. 
To solve an electromagnetic problem on a macroscopic level means to solve 
those equations when certain boundary conditions are known. Maxwell’s 
equations describe the relationships between the fundamental electromagnetic 
quantities. In this work the differential form is being used as it leads to partial 
differential equations that the finite element method can handle. Maxwell’s 
equations for general time-varying fields can be presented as: 
∇ × � = ۸ + ∂۲∂t  (2.2-1) 
∇ × ۳ = −∂۰∂t  (2.2-2) ∇ ∙ ۲ = ɏ (2.2-3) ∇ ∙ ۰ = Ͳ (2.2-4) 
1  
Where E - the electric field intensity, V/m; D – the electric displacement or 
electric flux density, C/m2; H – the magnetic field intensity, A/m; B – the 
magnetic flux density, V*s/m2;J – the current density, A/m2; ρ -  the electric 
charge density, C/m3. 
The first two equations are known as the Maxwell-Ampère’s law and Faraday’s 
law respectively. The third and fourth equations are electric and magnetic forms 
of Gauss’ law.  
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Another fundamental equation is called the equation of continuity and can be 
written as 
∇ ∙ ۸ = −∂ɏ∂t  (2.2-5) 
 
 
Three out of these five equations are independent. The first two combined with 
either the electric form of Gauss’ law or the equation of continuity form an 
independent system.  
2.2.2 Constitutive relations 
To achieve a closed system, we should include constitutive relations in the 
equations. These describe the macroscopic properties of the medium: ۲ = ɂ଴۳ + � (2.2-6) ۰ = μ଴ሺ� +ۻሻ (2.2-7) ۸ = σ۳ (2.2-8) 
  
Here ε0 is the permittivity of vacuum, μ0 is the permeability of vacuum, and σ the 
electric conductivity. In the SI system, the permeability of vacuum is chosen to 
be 4π·10−7 H/m. The velocity of an electromagnetic wave in a vacuum is given 
as c0 and the permittivity of vacuum can be found from the relation 
ɂ଴ = ͳc଴ଶμ଴ = ͺ.ͺͷͶ ∙ ͳͲ−ଵଶ F m⁄ ≈ ͳ͵͸Ɏ ∙ ͳͲ−ଽ F m⁄  (2.2-9) 
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The electric polarization vector P shows how the material is polarized in the 
presence of an electric field. It can be interpreted as the volume density of 
electric dipole moments and it is generally a function of E. Some materials can 
have a non-zero P even when there is no electric field. 
The magnetization vector M describes how the material is magnetized when a 
magnetic field H is present. It can be interpreted as the volume density of 
magnetic dipole moments and is generally a function of H. For permanent 
magnets M is not equal to zero also when there is no magnetic field present. 
We consider all the materials modelled in our study being as linear, which 
means that the polarization is proportional to the electric field, P = ε0 χe E , 
where χe is the electric susceptibility. That also means that magnetization is 
proportional to the magnetic field, M = χm H , where χm is the magnetic 
susceptibility. The constitutive relations for this type of materials are changed to: ۲ = ɂ଴ሺͳ + χୣሻ۳ = ɂ଴ɂ୰۳ = ɂ۳   (2.2-10) ۰ = μ଴ሺͳ + χ୫ሻ� = μ଴μ୰� (2.2-11) 
  
The parameter εr is the relative permittivity, and μr is the relative permeability of 
the material. The properties ε and μ are the permittivity and permeability of the 
material. For isotropic materials as in our study these are scalar properties. 
After setting the general equations we can proceed to our particular case. For 
impedance measurements the following two cases are most common. First one 
is when the direct current (DC) is applied to the system under study. In the 
second case the sinusoidal voltage or current is applied. It is a well known fact 
that in most biological systems such periodic input will induce periodic output.      
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2.2.3 Static case 
When the field quantities do not vary with time, the field is called static. In this 
case, (2.2-1), (2.2-2) and (2.2-5) can be re-written respectively as ∇ × ۳ = Ͳ (2.2-12) ∇ × � = ۸ (2.2-13) ∇ ∙ ۸ = Ͳ (2.2-14) 
  
whereas (2.2-3), (2.2-4), and (2.2-5) remain the same. It is evident that in this 
case there is no interaction between electric and magnetic fields; therefore, we 
can either have a separate electrostatic case described by (2.2-3) and (2.2-12) 
or a separate magnetostatic case described by (2.2-4) and (2.2-13), with 
(2.2-14) being a natural consequence of (2.2-13).  
2.2.4 Alternating current 
Eddy-current 
The range of frequencies, which is normally used for measuring living tissue 
impedance, is between 50Hz and 100MHz. With higher frequencies all 
electromagnetic properties of tissue becomes very close to the properties of 
water, so no useful information can be obtained . Thus for considered frequency 
range and average properties of biological matter the average depth of 
penetration [62] can be calculated: 
Ɂ = ͳ√fɎμσ (2.2-15) 
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where ݂ is the frequency, ߤ is the magnetic permeability, and � is the electric 
conductivity of materials. The lowest skin depth value is 30mm (for blood 
plasma and 100MHz), which is significantly higher than the characteristic size of 
analysed object (normally finger, or ear). Therefore there is no eddy current 
effect presented in all related problems. 
Time-harmonic fields 
When field quantities in Maxwell's equations are harmonically oscillating 
functions with a single frequency, the field is referred to as time-harmonic. 
Using the complex phasor notation [62], (2.2-1), (2.2-2), and (2.2-5) can be 
written in a simplified form as ∇ × ۳ = −jω۰ (2.2-16) ∇ × � = jω۲ + ۸ (2.2-17) ∇ ∙ ۸ = jωɏ (2.2-18) 
  
where the time convention ݁௝�௧ is used and suppressed and ߱ is angular 
frequency. It is evident that in this case, the electric and magnetic fields must 
exist simultaneously and they interact with each other, and it is also evident that 
the static case is the limiting case of the harmonic fields as the frequency ߱ 
approaches zero. The use of time-harmonic fields is not as restrictive as it first 
appears. Using Fourier analysis, any time-varying field can be expressed in 
terms of time-harmonic components via the Fourier transforms 
۳ሺtሻ = ∫ ۳ሺωሻejω୲dω+∞−∞  (2.2-19) 
۳ሺωሻ = ͳʹɎ∫ ۳ሺtሻe−jω୲dt+∞−∞  (2.2-20) 
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Therefore, if a time-harmonic field is known for any ߱, its counterpart in the time 
domain can be obtained by evaluating (2.2-19).  
The Quasistatic Approximation  
A consequence of Maxwell’s equations is that changes in time of currents and 
charges are not synchronized with changes of the electromagnetic fields. The 
changes of the fields are always delayed relative to the changes of the sources, 
reflecting the finite speed of propagation of electromagnetic waves. Under the 
assumption that you can ignore this effect, it is possible to obtain the 
electromagnetic fields by considering stationary currents at every instant. This is 
called the quasistatic approximation and is usually used in impedance 
tomography [63], [64].  
The quasistatic approximation implies that the equation of continuity can be 
written as ∇ ∙ ۸ = Ͳ (2.2-21) 
 
 
and that the time derivative of the electric displacement ∂D/∂t can be 
disregarded in Maxwell-Ampère’s law. Whereas Faraday’s law remains 
unchanged.  
In application to time-harmonic problem, the system of equations becomes  ∇ × ۳ = −jω۰ (2.2-22) ∇ × � = ۸ (2.2-23) ∇ ∙ ۸ = Ͳ (2.2-24) 
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The quasi-static approximation is to assume that  ω۰ = ωμ� (2.2-25) 
 
 
is negligible, so that  ∇ × ۳ = Ͳ (2.2-26) 
 
 
2.2.5 Potentials 
The Finite element method works with potential distribution. That means there is 
a need for formulation of an electromagnetic problem in terms of the electric 
scalar potential V and the magnetic vector potential A.  ۰ = ∇ × ۯ (2.2-27) 
۳ = −∇V − ∂߲ۯݐ  (2.2-28) 
  
The magnetic vector potential equation comes from the magnetic Gauss’ law 
(2.2-3). The electric potential one is a result of Faraday’s law (2.2-2). The 
general Maxwell equations for each specific case can be simplified to the 
domain equations combined with boundary conditions equations. Let us specify 
the domain equations for the cases which are used throughout this thesis. 
In static formulations, the induced current is zero. Maxwell-Faraday’s law 
reduces to Laplace’s equation [63] 
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∇ଶ߮ = Ͳ (2.2-29) 
 
 
For time-harmonic quasi-static systems solving for scalar potential, the 
formulation results in the following PDE obtained from (2.2-22), (2.2-23), and 
(2.2-24) with the substitution of (2.2-28): 
−∇ ∙ ሺɂ∇Vሻ + j߱ ∇ ∙ ሺσ∇Vሻ = Ͳ (2.2-30) 
 
 
which is normally solved with respect to electric scalar potential V by application 
of variational principle and spatial discretization. In this work, this equation is 
solved via Finite Element Method described below under assumptions also 
listed below. 
EM field assumptions: 
 Built model is linear (as none of the domain properties depend on field).  Material properties are isotropic as electrical properties of cholesterol, 
plasma and red blood cells (RBC) are independent of direction.  Permeability µ is set being constant and equal to this of vacuum. It is 
quite a common assumption for modelling of biological tissues [65], [66] 
as we consider no magnetic effects influencing impedance are 
presented in biological tissues under study.  The material properties are piecewise-homogeneous as there are 
cholesterol particles and RBC in blood plasma, material properties in 
domains are different.  The total volume of cholesterol is modelled as a number of spherical 
particles of relevant radius (calculated below) giving the same total 
volume. Further assumptions for modelling of cholesterol particles are 
given in the next Chapter. 
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 RBC are modelled as cylinders; radius to height ratio is taken from 
experimental data [67].  
 Following the numerical solution of the field equation, the current density is 
calculated by using the following equation ۸ = σ۳ = −σ∇V (2.2-31) 
 
 
2.2.6 Material Properties 
Until now, there has only been a formal introduction of the constitutive relations. 
These seemingly simple relations can give rise to complicated behaiviour at 
times. There are three main groups of materials where they require some 
consideration. A given material can belong to one or more of these groups. The 
groups are: 
• Homogeneous and inhomogeneous materials 
• Isotropic and anisotropic materials 
• Linear and nonlinear materials 
 
The least complicated of the groups above is that of the inhomogeneous 
materials. An inhomogeneous medium is one where the constitutive parameters 
vary with the space coordinates, so that different field properties prevail at 
different parts of the material structure. 
For anisotropic materials, the field relations at any point are different for 
different directions of propagation. This means that a 3-by-3 tensor is required 
to properly define the constitutive relations. If this tensor is symmetric, the 
material is often referred to as reciprocal. In these cases, the coordinate system 
can be rotated in such a way that a diagonal matrix is obtained. If two of the 
diagonal entries are equal, the material is uniaxially anisotropic. If none of the 
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elements have the same value, the material is biaxially anisotropic [68]. An 
example where anisotropic parameters are used is the conductivity when 
modelling solenoids. 
Nonlinearity is the effect of variations in permittivity or permeability with the 
intensity of the electromagnetic field. This also includes hysteresis effects, 
where not only the current field intensities influence the physical properties of 
the material, but also the history of the field distribution. 
Finally, dispersion describes changes in the velocity of the wave with 
wavelength. In the frequency domain, dispersion is expressed by frequency 
dependence in the constitutive laws. 
As for our system it has been considered inhomogeneous (heterogeneous), 
isotropic and linear (see Chapter Model Assumptions). 
2.2.7 Boundary and Interface Conditions 
To get a full description of an electromagnetics problem, boundary conditions at 
material interfaces and physical boundaries are needed. At interfaces between 
two media, the boundary conditions can be expressed mathematically as �૛ × ሺ۳૚ − ۳૛ሻ = ૙ (2.2-32) �૛ ∙ ሺ۲૚ − ۲૛ሻ = ɏୱ (2.2-33) �૛ × ሺ�૚ − �૛ሻ = ۸� (2.2-34) �૛ ∙ ሺ۰૚ − ۰૛ሻ = Ͳ (2.2-35) 
  
where ρs and Js denote surface charge density and surface current density, 
respectively, and n2 is the outward normal from medium 2. Of these four 
conditions, only two are independent. One of the first and the fourth equations, 
Mathematical Modelling of Electromagnetic Field Distribution in Conductive 
Suspension  
 
35 
 
together with one of the second and third equations, form a set of two 
independent conditions.  
A consequence of the above is the interface condition for the current density, 
�૛ ∙ ሺ۸૚ − ۸૛ሻ = −∂ɏୱ∂t  (2.2-36) 
 
 
In case of our bioimpedance studies boundary conditions on the interface are:  Eଵ� = Eଶ� (2.2-37) Dଵ௡ = Dଶ௡ (2.2-38) ɂଵEଵ୬ = ɂଶEଶ୬ (2.2-39) 
We assume that a homogeneous electric field E is applied along the z-axis.  
When conductors are involved, the source term representing charge density 
vanishes and it is replaced by boundary conditions of the Dirichlet type, 
modelling a constant-voltage surface (perpendicular to the electric field). 
2.2.8 Impedance 
The impedance technique has been successfully used in many areas (industry, 
chemical production, pharmacy, medicine, biosciences) and it has allowed to 
create reliable qualitative tools for imaging (EIT, ERT) [6], [64], [69] and for 
quantitative analyses (BMI, fuel purity, food quality, impedance spectroscopy) 
[65], [70]–[78]. 
Bioimpedance is something that deals with passive electrical properties 
of bio-tissues, it shows tissue ability to oppose (impede) electric current. The 
biological tissues can be seen as a volume conductor or a dielectric. With 
frequencies lower than 100 kHz most of the tissues are assumed being 
electrolytic conductors. At higher frequencies (e.g. 50 MHz), the dielectric 
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properties of bio-tissue may dominate.  The higher the frequency the closer 
tissue properties come to those of water [65], [79]. The impedance of blood is 
purely resistive for the range of frequencies up to 100 kHz [80]. 
Impedance is a ratio between voltage and current. The following equation can 
be used in both direct and alternating current cases: 
Z = VI  (2.2-40) 
 
 
Although it is a very simple ratio, it cannot be calculated analytically for most of 
the biological systems. So for both direct current and alternating current it is 
more important to link these quantities with properties of materials. 
Direct current case (DC) 
 When the direct current is applied the impedance of our system contains only 
resistivity and can be calculated using following equations: 
R = VI = ElσES = lσS (2.2-41) 
 
 
where l is current path length, σ – material conductivity, S – cross-section. 
 This is valid only for a situation when no particles are present in between 
electrodes and the full volume is filled with blood plasma and  it is also being 
assumed a homogeneous and isotropic medium (current density and E-field 
directions are coinciding) [65] .  
In case of particles being present in the solution the system can be modelled as 
a superposition of series and parallel resistances and the effective impedance 
will be calculated using well-known equations. Some of the extreme cases are 
being looked at in Chapter 4.   
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Alternating current case (AC) 
In case of alternating current the impedance will consist of two parts: 
Z = VI  (2.2-42) Z = R + jX (2.2-43) 
X = ωL − ͳ߱ܥ (2.2-44) 
Z = R + ͳ݆߱ܥ (2.2-45) 
  
As we do not consider blood components to have inductance it can be seen 
from (2.2-43) that at high frequencies impedance becomes purely resistive. If 
properties of the medium are known than (2.2-45) can be evaluated into intrinsic 
impedance of the conductive medium[46]: 
Z଴ = √ jωμσ + jωɂ (2.2-46) 
  
It is more convenient to work with tissue properties, such as conductivity, 
permittivity and permeability rather than with resistance, capacitance and 
inductance. Replacing J in (2.2-1)  with (2.2-31), will get [62]: 
∇ × � = σ۳ + ∂۲∂t  (2.2-47) 
  
In case of current flowing in x direction: 
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−∂H௭߲ݔ = σE௬ + jωɂE௬ (2.2-48) 
  
According to the ratio  
media can be classified as being a conductor or a dielectric (߱ = ʹߨ݂, radian 
frequency) [62]. 
 
Dielectrics: σωɂ < ͳͳͲͲ 
Quasiconductors: ͳͳͲͲ < σωɂ < ͳͲͲ 
Conductors: ͳͲͲ < σωɂ 
  
Calculations of (2.2-49) ratio for biological tissues are presented in the next 
chapter. 
2.3 Finite Element Modelling 
2.3.1 Finite element basics 
In a case of homogeneous or composite materials for a known set of excitation 
parameters and material properties any problem can be solved in terms of 
σωɂ (2.2-49) 
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current or electrical field distribution using Maxwell’s equations. There are only 
two types of problems that are solved in differential equation, boundary value or 
initial value problems. If the values of the unknown parameter is given at a point 
(e.g. at particular time) and the task is to find values for all other time points, it is 
called initial value problem. When parameter values are given on the material 
boundaries and the values on the inside are to be found, this is called a 
boundary value problem. For most bioimpedance problems boundary value 
problems are solved (e.g. known current or voltage drop on electrodes and 
unknown field distribution within the volume of interest). 
Maxwell’s equations in their differential form describe behaviour of our system. 
The problem is that this way they describe an infinite-dimensional object. To 
overcome this issue, finite-dimensional approximation must be used. It can be 
done by means of two main approximations: finite difference or finite element 
method. The core of finite difference method is replacement of the differential 
equations (DE), describing the continuous change of parameter values, with 
approximations that describe the slope of change between the finite number of 
discrete points (mesh points). For FEM it is division of the domains into smaller 
volumes - elements and expression of unknown solutions in the form of the 
weighted sum of basis functions, which are polynomials in each element [65].    
The main function of the finite element method is to proceed from the form of 
DE to a system of joint equations, which can be solved by a computer. That is 
made by minimization of energy functional.  Non-linear equations are then 
linearized using different methods (that depends on software). The set of 
solution is then connected directly or by means of simple computations to 
unknown quantities of interest.  
The first step in finite element analysis is a creation of mathematical FE model, 
which geometrically represents the physical structures under investigation. The 
starting point for the finite element method is a mesh, a partition of the geometry 
into small units of a simple shape, mesh elements, and then the values of the 
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unknown variables under study are calculated in selected points of those 
elements. These points are called “nodes”. Division of the body into elements is 
called discretisation and the whole solution of the problem depends on the way 
it is made. As build mathematical model represents the actual physical one, the 
actual physical properties should be assigned to model parts that are ‘made’ of 
that material. 
The idea of the method is described in detail in [81]. According to the 
mathematical formulation, the considered unknown field variable ݑ in the 
equation like (2.2-29) and (2.2-30) can be approximated throughout a set of 
functions ߯௜. Each of these functions has simple structure and most commonly it 
is the polynomial function of second order. Subdividing the entire space Ω onto 
the number of simple volumes, it is possible to calculate the distribution of the 
unknown in the space and approximate each volume as a uniform subspace 
which has the internal distribution of unknown as ߯௜. Considering the shearing 
boundary conditions of two neighbour elements and providing the conditions for 
external surface, the linear system of equations could be written and then 
solved. More formally, in the simple case for 3D problem we can write an 
equation for our unknown ݑ: 
ݑሺݔ, ݕ, ݖሻ = ∑ݑ௞߯௞ሺݔ, ݕ, ݖሻே௞=ଵ  (2.3-1) 
 
 
For the external loading function ݂ሺݔ, ݕ, ݖሻ we achieve the same structure as:  
݂ሺݔ, ݕ, ݖሻ = ∑ ௞݂߯௞ሺݔ, ݕ, ݖሻே௞=ଵ  (2.3-2) 
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Then, using substitution for our first order differential problem we have the 
following system of linear first order equations: 
−∑ݑ௞∫ ∇߯௞ ∙ ∇߯௝Ωே௞=ଵ ܸ݀ = ∑ ௞݂ே௞=ଵ ∫ ߯௞߯௝Ω ܸ݀ ݂݋ݎ ݆ = ͳ,… , ܰ (2.3-3) 
 
 
Using the matrix-vector form we obtain: −ۺ� = ۻ� (2.3-4) 
 
 
where matrixes ۺ and ۻ are calculated from the equation (2.3-3): 
ܮ௞௝ = ∫ ∇߯௞ ∙ ∇߯௝Ω ܸ݀ 
 ܯ௞௝ = ∫ ߯௞߯௝Ω ܸ݀ 
 for ݆, ݇ = ͳ,… ,ܰ 
(2.3-5) 
 
 
Considering the electromagnetic quasistatic simulations (f is constant and fully 
determined), the problem can be described in following form in terms of 
unknown magnetic potential ߮ሺݔ, ݕ, ݖሻ:  ۹φ = � (2.3-6) 
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Where ۹ and � are the coefficient matrix and boundary condition vector 
respectively [82].  
2.3.2 FEM application to impedance of conductive suspension 
If a potential distribution  on the electrodes is known (Figure 4.1–2, Figure 5.1–
2) then the electric field distribution between these electrodes in the 2D ( (x,y)) 
or 3D ( (x,y,z))   problem domains is given by equation (2.2-29) and is solved 
by means of finite element method (FEM) in .  It is solved in terms of potential  with appropriate boundary conditions and using conductivity () and 
permittivity () values distribution for problem domain . It is all done under 
assumptions summed up in 2.2.5 and 2.2.6. Following the solution of equation 
(2.2-29), field intensity and flux density vectors E=–gradV (V is the potential 
difference) and D=E are calculated. From these the current I=JA (A is the 
cross-sectional area) is calculated using current density (2.2-31). 
In COMSOL [83] the set of equations is solved using generalized minimum 
residual (GMRES) method described in  [84]. This is an iterative method for 
general linear systems of the form Ax = b. For fast convergence it is important 
to use an appropriate preconditioner, which conditions a given problem into a 
form that is more suitable for numerical solution. This means that the condition 
number decreases and changes the problem from ill-conditioned to well-
conditioned. GMRES method uses the left preconditioned system: �−ଵሺۯݔ − �ሻ = Ͳ (2.3-7) 
 
 
which gives the same solution as the original system so long as the 
preconditioner matrix P is non-singular. 
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The goal of this preconditioned system is to reduce the condition number of the 
left preconditioned system matrix P-1A.  
There is a trade-off in the choice of P. Since the operator P-1 must be applied at 
each step of the iterative linear solver, it should have a small cost (computing 
time) of applying the P-1 operation. P is usually chosen as somewhere between 
P=I and P=A, in an attempt to achieve a minimal number of linear iterations 
while keeping the operator P-1 as simple as possible.  
Each element calculation introduces a small error to the overall solution, but 
ideally it is supposed to diminish as a number of nodes and respectively 
elements increases. However in a case of ill-posed problem there is no certainty 
that the overall sum of diminishing errors will not have a large impact on overall 
solution. This is why several verifications are supposed to be used for every 
computational model. This included mesh convergence study and test with 
simple analytical solution, where possible. 
When an iterative solver in COMSOL Multiphysics is used, it estimates the error 
of the solution while solving. Once the error estimate is small enough, as 
determined by the convergence criterion �|�−ଵሺۯݔ − �ሻ| < ݐ݋݈ ∙ |�−૚�|, (2.3-8) 
 
 
 
the software terminates the computations and returns a solution. When a direct 
solver COMSOL Multiphysics is used it can optionally make a check (Error 
check), to determine if the above convergence criterion is fulfilled after the 
solution step. If the error criterion is not met, the solution process is stopped an 
error message is given. In (2.3-8) P is a preconditioner matrix. The convergence 
criterion (2.3-8) states that the iterations terminate when the relative 
(preconditioned) residual times the factor ρ called stability constant is less than 
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a tolerance tol. The  factor ρ in the Factor in error estimate field (default = 
400). For solvers where P is equal to the identity matrix, the iterations can 
sometimes terminate too early with an incorrect solution if the system matrix A 
is ill-conditioned. For solvers where P is not equal to the identity matrix, the 
iterations can sometimes terminate too early if P is a poor preconditioner. If the 
iterations terminate too early due to an ill-conditioned system matrix or a poor 
preconditioner, the ρ factor should be increased to a number of the order of the 
condition number for the matrix P−1A. If ρ is greater than the condition number 
for the matrix P−1A, the convergence criterion implies that the relative error is 
less than tol:  |ݔ − ۯ−૚�| < ݐ݋݈ ∙ |ۯ−૚�| (2.3-9) 
 
 
In general larger value of ρ increases the number of iterations, but decrease the 
chance that the iteration is terminated too early [83]. 
In the presented COMSOL solution, accuracy due to discretization was 
controlled by the relative tolerance value. For all of the simulations it has been 
kept at a value of 0.001, which sets estimated error maximum at 0.1%. Once 
the error estimate is small enough the software terminates the computations 
and returns a solution. If the error criterion is not met, the solution process is 
stopped and an error message is given.   The real global error LinErr can be 
found from convergence graph that is plotted along the solution or in custom 
generated report file. 
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   Chapter 3. Realisation of Finite Element 
Model of Non-invasive Cholesterol 
Measurement System 
3.1 Introduction 
Mathematical model is a representation of a real system made using 
mathematical concepts and language. For that, several assumptions have to be 
made. The first step is to select the area of the body where electrodes are going 
to be placed. 
 Blood for cholesterol tests is withdrawn from the vein, usually on left arm. So it 
is suggested that a vein model should be built. But as the method is non-
invasive this means that electrodes are placed at the skin surface, the simplest 
model will involve arm modelling. On the other hand, it highlights several 
problems. The most important is the electrode positioning and placement.  It is 
necessary to look at all possible situations to find the most suitable for 
modelling.  
If the arm is chosen as a place for electrodes: it gives a choice of number of 
electrodes to be used.  Due to some effects stated in [65] (e.g. arising 
complexity of field distribution and interference) the best system for our purpose 
is a 2-electrode system.  Two positions for electrodes are possible: on the same 
side of the arm along the vein or on opposite sides. In the first case it is hard to 
predict the pass current will take and the portion of current that will reach the 
electrode. In the second case, again current pass is not easy to predict, it also 
raises such problems as eddy-current, and complexity of the mathematical 
model, representing skin-vein-bone-skin system. 
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Taking all of that into account the other place of interest was picked: the 
earlobe. It does not have a bone inside; its average thickness is less than skin-
depth for frequency ranging from 1Hz up to 100 MHz. There are several 
assumptions that are to be made to reduce the complexity of the system for 
modelling purposes.  First, is capillary blood content the same as venous?  It 
has been proven in  [85], [86] that there is no significant difference between 
samples taken from vein and finger-tip, which means that ear capillaries are 
suitable for modelling and representing total cholesterol measurement system. 
Electrodes are placed on opposite sides of earlobe. Two electrodes system also 
helps to eliminate (or at least reduce) the effect of parasitic capacitances in 
setup in the frequency range over 12 kHz up to 100 MHz [65], [87].  
3.2 Model of non-invasive measurement of cholesterol 
So earlobe has been selected as a most suitable place for performing non-
invasive impedance cholesterol measurements. 
Capillary fulfil the whole volume of earlobe this gives a possibility to model the 
earlobe as a volume filled with blood. Average earlobe thickness has been 
selected equal to 5 mm.   
Earlobe size varies, so the electrodes should be selected to suit all people.  
This led to electrode size being selected at 5mm. The next step is to choose 
electrode material.  
There is a whole variety of materials used for electrode production:  silver-silver 
chloride, platinum metals, gold, titanium, stainless steel, tin, lead, nickel, silver, 
zinc, iron, aluminium, carbon, polymers. And even though some of them are not 
biocompatible and some are noisy or polarizable, it still leaves us with a lot of 
choice. As no choice has been made and no particular electrode material has 
been selected, a decision has been made to model electrodes as two hollows. It 
also allows overcoming problem of some software to model metals, as for most 
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of existing programs the usage of real properties of metals will not lead to 
obtaining correct results. However there is a method of overcoming this issue 
by assigning metal domains a very high value for permittivity [88]. One of the 
test runs performed have shown that this technique does not work in COMSOL. 
Voltage values are put on all of the surfaces that ‘build’ the electrode. It is 
assumed that skin does not influence impedance of the system, which in 
practice means that there is a conductive gel in between electrode and skin 
surface that moisturizes skin, making its conductivity higher and takes care of 
the air gap between the electrode and the skin.   
The last step is to decide what assumptions should be made for blood 
modelling. Human blood is a complex suspension that is composed of cells of 
different size and shape (red blood cells, platelets, etc.) distributed in an 
aqueous solution called the plasma, which means that in reality it is highly 
inhomogeneous material. But for modelling purposes spherical particles 
suspended in a solvent is a first iteration in building a blood model. Volume 
content is as following: 55 % of volume is blood plasma, 45 % are formed 
elements (blood cells). Blood plasma contains 91.5% of water and has lipids, 
salts, glucose, amino acids, vitamins, hormones, and waste products of 
metabolism presented in [67]. For simplification of the model it is proposed to 
investigate the impedance impact of pure cholesterol, excluding all the blood 
cells and other particles as a first iteration. 
The electrical properties (e.g. electrical conductivity,  and dielectric 
permittivity,) of whole blood are very different from those of blood plasma, 
which contains no cells [89], [90]. In addition, as the idea is to find how total 
cholesterol (TC) number is transformed into impedance signal. This means that 
usage of total blood characteristics is not correct in that case.  Therefore, for the 
basic mathematical model blood has been modelled as a suspension, 
containing only blood plasma and cholesterol. As all the constituents of blood 
plasma are presented in small quantities it is displaced within the model with 
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0.9% physiological saline solution that is commonly used in blood transfusion 
because of being isotonic with blood plasma [91].  
Finally yet importantly is a blood flow assumption. It is well known that 
frequency of a heart beat and therefore of blood pulsation leading to blood 
movement is about 1 Hz. In comparison with frequency of current (50 kHz) it is 
low enough to consider blood and hence blood particles stationary objects. 
The next iteration is to calculate volume proportion of blood plasma occupied by 
cholesterol using TC level value.  In most of the cases once the results of the 
blood tests come in, there is a number characterizing level of cholesterol 
presented in blood. In the UK the unit for cholesterol levels is mmol / L 
(millimoles per litre).  But what does it mean if someone is told to aim for a total 
cholesterol level equal to 5 mmol/L?  
The percentage of given volume occupied by cholesterol molecules using 
information on HDL and LDL is calculated (Appendix 1). It has been done in two 
different ways to ensure that results obtained with one methods correlate well 
with those calculated differently.  
Clearly, it is not possible to model separate cholesterol molecules as firstly, they 
are too small in comparison with selected model size and secondly there are 
hardly any free cholesterol particles presented in blood stream. Moreover even 
single HDL or LDL particles are not modelled as their size is still too small and 
taking each and every of them into account would dramatically increase the 
time of solution. As it is going to be proven it is not necessary to model all of 
them. Cholesterol molecules will be joined into bigger particles, which are going 
to be modelled. This can be proven by the review of the ways biological tissues 
have been modelled in past decades.   
An effective conductivity of dilute suspension in aqueous media of spherical 
particles (that do not have a permanent electric moment) has been derived by 
Maxwell [92]. First let us take a spherical particle of radius R and conductivity 
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σpart  and place it into a homogeneous solvent with conductivity σe and apply a 
uniform electric field E0 (see Figure 3.2–1) 
 
Figure 3.2–1. Particle in electric field, σe > σpart 
In case of our study the conductivity contrast is equal to 70 (Table 3.1). 
Table 3.1. Material properties assigned to the domains of the problem 
     Frequency 
 
Material 
1 kHz 50 kHz 1 MHz 10 MHz 100 MHz 
σ, S/m 
Blood base 1.76 1.76 1.9 2 2 
Cholesterol 0.025 0.025 0.03 0.04 0.06 
Whole blood 0.7 0.7 0.7 0.8 1 
εr 
Blood base 106 79 0.001 0.0001 0.0001 
Cholesterol 2*104 10000 50 30 12 
Whole blood 4*103 4*103 2*103 100 40 
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This table shows that blood plasma is a much better conductor then cholesterol 
particles. This contrast is a quality that is used in our research as a main 
instrument for cholesterol level measurement.  
An equation for the potential outside the particle is found from the Laplace 
equation with the proper boundary conditions using spherical co-ordinates. The 
centre of coordinates (r, θ, φ) is in the middle of the sphere. In that case the 
potential is [93]: 
ܸሺݎ, �ሻ = −ቆͳ + �௘ − �௣௔௥௧ʹ�௘ + �௣௔௥௧ ܴଷݎଷቇܧ଴ݎܿ݋ݏ� (3.2-1) 
ܸሺݎ, �ሻ = −ቆͳ + ܰ �௘ − �௣௔௥௧ʹ�௘ + �௣௔௥௧ ܴଷݎଷቇܧ଴ݎܿ݋ݏ� (3.2-2) 
 
 
 If we look at that model from macroscopic point of view, we see a spherical 
shaped medium with an aqueous solution of spherical particles inside it.  A 
potential outside the big sphere is given by the expression (1.2-25), where σpart  
is replaced by the effective conductivity and at a distance  r>R’:  
ܸሺݎ, �ሻ = −ቆͳ + �௘ − �௘௙௙ʹ�௘ + �௘௙௙ ܴ′ଷݎଷ ቇܧ଴ݎܿ݋ݏ� (3.2-3) 
 
 
where σeff  is the effective conductivity of a sphere that contains N particles. 
Volume fraction occupied by particles: ݌ = ܴܰଷ/ܴ′ଷ (3.2-4) 
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gives a possibility to find effective conductivity σeff from the Maxwell’s mixture 
equation: �௘ − �௘௙௙ʹ�௘ + �௘௙௙ = ݌ �௘ − �௣௔௥௧ʹ�௘ + �௣௔௥௧ (3.2-5) 
 
 
As mentioned above biological cells have complex geometry, so the Maxwell’s 
mixture equation has been modified for ellipsoidal particles  that are orientated 
in parallel by Sillars [94]. When p is very low and the field is applied along the a-
axis it gives: 
�௘௙௙ = �௘ [ͳ + ݌ሺ�௣௔௥௧ − �௘ሻ�௘ + ሺʹ�௣௔௥௧ − �௘ሻܮ௔] (3.2-6) 
 
 
 Where La is the depolarization factor of the ellipsoid in the a-axis direction [95]: 
ܮ௔ = ܾܽܿʹ ∫ ݀ݏሺܽଶ + ݏሻ√ሺܽଶ + ݏሻሺܾଶ + ݏሻሺܿଶ + ݏሻ∞଴  (3.2-7) ܮ௔ + ܮ௕ + ܮ௖ = ͳ (3.2-8) 
 
 
Where a, b and c are the semi-axis of the ellipsoid. In case of spherical particles  a = b = c the depolarization factor L௔ = ͳ ͵⁄  [96]. That gives: 
�௘௙௙ = �௘ [ͳ + ͵݌ሺ�௣௔௥௧ − �௘ሻ͵�௘ + ሺʹ�௣௔௥௧ − �௘ሻ] (3.2-9) 
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These calculations show that blood plasma and cholesterol system can be 
represented by conductive solution with cholesterol particles combined into 
particles of relevant radius. 
Taking into account the atherosclerotic plaque structure and suggestions made 
by Stiles and Oakley in  [97]  we can use those conductivity and permittivity 
values in our simulation. Material properties assigned to domains are presented 
in Table 3.1. There are several values for physiological saline (blood base) 
conductivity at the given frequency band ranging from 2 S/m [65] down to 1.4 
S/m [98]. The decision has been made to take conductivity value that lies in 
between the two and has been found in  [99]–[101]. 
Although real conductivity and permittivity values for various tissue vary 
significantly, Figure 3.2–2shows typical curves for displacement and conduction 
components of the total current. In the used range of frequencies there is a 
visible domination of conduction current over displacement.  
 
Figure 3.2–2. Conduction current Ic and displacement current Id for a typical 
tissue [66] 
A set of simulations have been performed to recreate some of the possible 
situations and investigate what parameters are putting an impact on impedance 
of system under study. Results are presented in next two chapters.
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   Chapter 4. Modelling of Non-invasive 
Cholesterol Measurement System in 2D 
4.1 Building a 2D model  
In 2D the basic model comprises of six air domains, three blood plasma 
domains and two hollow domains representing electrodes. The whole model 
measures 35×20 mm2. This model is shown in Figure 4.1–1. The size of upper 
and lower blood-base domains is selected because in reality earlobe size is 
bigger than the size of an electrode and as distance between electrodes is 
comparable with their size we should consider that a fringe effect will have 
significant influence on impedance of the system. Manual 2D model set up file 
can be found in Appendix 2. 
It is simply not possible to model separate cholesterol molecules. So, as it has 
been previously mentioned, the equivalent cholesterol volume has been 
calculated and the whole amount of cholesterol is divided into smaller particles 
for modelling purposes [102].   
Knowing the total volume of cholesterol in 1 mm3 of blood plasma, we can 
calculate amount of cholesterol in the volume being modelled. In 2D area of 
interest is a square 5×5 mm2. Now we can calculate the volume of cholesterol in 
blood plasma cube. 
The volume occupied by cholesterol in 125 mm3 is: 
ଵܸଶହ௠௠య = ௖ܸℎ௢௟ ௜௡ ଵ ௠௠య ∗ ܸ = ͳ.ͺ͹ ∗ ͳͲ−ଶ ∗ ͳʹͷ = ʹ.͵Ͷ ݉݉ଷ (4.1-1) 
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If it is assumed that all the cholesterol particles form a sphere shape, then the 
radius of that sphere is: ݎ = √͵ ∗ ܸ/ሺͶ ∗ ߨሻయ = √Ͳ.ͷͷͻయ = Ͳ.ͺʹͶ ݉݉ (4.1-2) 
 
 
That means that area of the great circle (Riemannian circle) for that sphere is: ܵ = ߨ ∗ ݎଶ = ʹ.ͳ͵͵ ݉݉ଶ (4.1-3) 
 
 
The fraction will be: 
�ௌ = ܵܵ଴ = ʹ.ͳ͵͵ ݉݉ଶʹͷ ݉݉ଶ = Ͳ.Ͳͺͷ (4.1-4) 
 
 
Therefore, this means that in the plane of great circle the cholesterol particle will 
take 8.5% of the whole volume of blood.  
It is obvious that there will be dependence between number of particles that 
cholesterol is divided into and impedance of the system. To calculate radius of 
each particle we need, in case of 2D modelling, to divide the whole area by 
number of particles and then radius of one sphere will be equal to:  
ݎே = √ ܵܰ ∙ ߨ (4.1-5) 
 
 
For greater feasibility, those N particles should be distributed randomly. It is 
being taken care of by introducing following method. The number of particles is 
divided so that it gives equal (where possible) number of rows and columns. 
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Therefore, it is a good idea to set N equal to the square of some number. 
Radius of one sphere is calculated. Then the whole area is divided into N small 
squares, a particle is set in the middle of each square and then using random 
number generator the particle is shifted from that position. As COMSOL can 
work with MathLab files as input, such file has been made to facilitate the model 
creation. An example of such file is presented in Appendix 4. 
The random particle distribution realisation is presented in Figure 4.1–1. The 
algorithm of random particle generation is demonstrated in detail in Appendix 4. 
 
Figure 4.1–1. Coagulated cholesterol particles in blood plasma  
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Figure 4.1–2. Boundary conditions 
Outside geometry edges have ground as a boundary condition. Voltage is 
applied to all the boundaries surrounding hollows. Voltage values have been 
decided on using next set of assumptions: maximum current should not be 
more than 30 mA as it is an average pain threshold in human; voltage is divided 
in by two and applied symmetrically on both electrodes as this helps to simplify 
theoretical validation using field lines and voltage and current distribution 
graphs. We assume that current passing through is of 10mA and use whole 
blood conductivity to find relative voltage [65]. From that statement, voltage 
values can be calculated from set of simple equations:  
ܫ = ܸܴ = �ܸ݈ܵ  (4.1-6) 
ܸ = ܫ݈�ܵ (4.1-7) 
 
 
This gives Vel=±1.428V.  
Boundary conditions are put on the outer edges (as in FE modelling all 
conditions inside the volume simulated are resolved automatically): 
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  ܸ = Ͳ (4.1-8) 
 
 
Mesh analysis was performed and its results are presented in 4.2. Fragment of 
custom mesh has been selected and the mesh of model with 100 particles in is 
displayed in Figure 4.1–3 
 
 
Figure 4.1–3. 2D custom mesh for 20 particles 
 
A quantity that characterize mesh in COMSOL is called mesh element quality 
and is calculated from:. 
q = Ͷ√͵Ahଵଶ + hଶଶ + hଷଶ (4.1-9) 
Modelling of Non-invasive Cholesterol Measurement System in 2D 
 
58 
 
 
 
where A is area and h1, h2, h3 – sidelights.  Value of q lies between 0 and 1 and 
the closer it gets to 1 the closer element shape comes to an equilateral triangle. 
This criterion is stronger than used in most of the other software products. 
Everything above value of 0.3 is considered a good mesh, which means that the 
mesh quality does not affect the solution quality. Also extra care should be 
taken if any warnings come up regarding possible inverted elements, as this 
may significantly affect local solution. Our goal for 2D was to keep average 
element quality above 0.9 and minimum element quality above 0.3 [83]. 
Maximum element growth rate is 1.3, which means that difference in size 
between two adjacent elements cannot exceed 30 %. 
 
Figure 4.1–4. Custom mesh for 1 particle of coagulated cholesterol 
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4.2 Results and discussions on 2D Model 
4.2.1 Mesh convergence study 
As it was suggested in the previous Chapter, current values will vary according 
to the size of the particle selected. So it was suggested for the first simulation 
set to find dependence of current per unit length (as we are solving a 2D 
problem) from number of particles. In parallel for each step a mesh 
convergence study has been performed. The aim of that study is to find such 
optimal size of mesh elements that further decrease in element sizing will not 
make a difference in solution (the only difference will be time consumption). 
None of the build-in meshes was considered appropriate and a custom made 
mesh has been created. The difference between ‘good’ and ‘bad’” mesh (its 
influence on solution) is shown on following Figures (Figure 4.2–2, Figure 4.2–
3, Figure 4.2–4). The cut-line for those graphs is shown in Figure 4.2–1. The 
drop in current value on graphs shows cholesterol particles position, for 
example the square shaped one is a particle that is crossed by a cut-line right in 
the middle. From those graphs it is obvious that the fine mesh presented in 
Figure 4.2–4 gives smooth solution and further refinement will only lead to 
increase in computation time of the problem.  
One of the mesh convergence study curves is shown below to describe the way 
the number of elements influences solution (Figure 4.2–5). This figure shows 
that after certain point (Ne=6000) curve comes to plateau and further refinement 
does not have any sufficient impact on quantity of interest. Resulting number of 
particles–electric field dependence has been traced and related curve can be 
seen in Figure 4.2–6. 
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Figure 4.2–1. Cut-line for mesh convergence study 
 
Figure 4.2–2. Electric field distribution for the coarse mesh (Nel=1380) 
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Figure 4.2–3. Electric field distribution for the less-course mesh (Nel= 6875) 
 
 
Figure 4.2–4. Electric field distribution for the fine mesh (Nel=11857)  
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Figure 4.2–5. Mesh convergence study 
 
Figure 4.2–6. Variation of current per unit length with number of particles 
As it was predicted, after reaching certain Nparticles curves reaches the plateau 
region and stops changing. That means that one of the assignments proves to 
be right and that cholesterol in such case can be modelled as separate particles 
being united in bigger particles without significant solution change. It also can 
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be noticed that the dispersion decreases when we increase number of 
elements. This is again something that is expected and is a basic property of 
FEM.  
This graph gives a possibility to say that 100 particles in 2D case are enough to 
represent cholesterol particle distribution in blood plasma. 
Even though DC analysis highlights difference in impedance for cholesterol-
blood plasma system, once other particles are introduced to the suspension the 
only way to distinguish which particle type produced the impedance change is 
frequency analysis. So the next step is to perform frequency analysis of our 
model.  
Frequency analysis has been performed for a fixed number of particles equal to 
100.  
4.2.2 Frequency analysis 
Frequency analysis gives set of curves: with and without cholesterol (Figure 
4.2–8). These results show that in case of our model the preferable frequency 
lies between 50 kHz and 100 MHz. That means that more factors should be 
taken into account. To choose the right frequency we should consider: 
 The frequency of voltage/current should be higher than frequency of 
heart beat, so that we can ignore the movement of blood particles (and 
relevant magnetic field effects), which means that DC cannot be used.  At high frequency (500-700 kHz - MHz-range) current will get through 
blood cells [65].   
So taking all of those facts into account 50 kHz frequency has been selected. 
As it is also shown by several publications it is of the typical range for 
impedance measurements [103], [104] . 
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Figure 4.2–7. Cut-line for frequency analysis 
Modelling of Non-invasive Cholesterol Measurement System in 2D 
 
65 
 
 
 
Figure 4.2–8. Current density along cut-line, area of interest filled with: a) 
plasma and coagulated cholesterol particles, b) plasma 
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The last effect to be checked for building a valid model is fringe field effects.  
There is a well-known effect that electric field of capacitor does not end abruptly 
at the edge of capacitor plates, but tend to bulge (extend) on both sides. The 
fringing can be taken care of by increasing the volume of the model in vertical 
direction, so that is why it has been extended by 7.5 cm at both ends from the 
volume of interest. The fringe field effect is illustrated in the figures below 
(Figure 4.2–9 and Figure 4.2–11).  
 
Figure 4.2–9. Vectors showing current density distribution for 100 particles 
The other phenomenon that should be monitored closely is potential lines in 
regards to the boundary position. It is known that putting boundaries to close to 
the area of interest can lead to potential lines deformation, which would lead to 
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incorrect solution. Because of that geometry had to be extended both vertically 
and horizontally (Figure 4.2–10).  
 
Figure 4.2–10. Electric potential plot showing the extension for correct electrical 
field calculation 
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Figure 4.2–11. Extension of geometry in vertical direction 
The positioning of particles can play a huge role in resulting current. Several 
extreme cases have been modelled. Some of them can be approximately 
simulated by the series or parallel impedances.  Size of each particle has been 
calculated in such way that the line of particles blocks the whole volume. These 
studies and results are presented above in Figure 4.2–11. This study is linked 
with theoretical validation of the model below. 
4.2.3 Analytical validation of 2D models 
First step is to calculate current per unit length using model where only the 
volume between electrodes is filled with blood plasma, all the other domains are 
assigned air properties, no cholesterol presented. That way no current leaves 
the volume of interest, making it easier to calculate current per unit length using 
equation: 
Id = Vσbl = ͷ.Ͳ͵ �/݉ (4.2-1) 
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COMSOL result is  Iୢ = ͷ.Ͳ͵ �/݉. This shows that at this stage modelling 
agrees well with theoretical results. 
We can also estimate fringe effect using current per unit length in z-direction 
along the cut-line going through the middle of geometry. 
 
Figure 4.2–12. Positioning of the cut-line for estimation of fringe field effects 
 
From data presented in Table 4.1 it can easily be seen that fringing gives about 
40% of the total current. In reality, there is cholesterol present above and below 
the area of electrode placement, which will reduce the fringe effect, but it will 
also mean that somehow this cholesterol will affect impedance of our system. 
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However, for the moment we assume that major change in impedance is only 
due to the cholesterol present in the region of interest. 
 
Table 4.1. Current per unit length in z-direction of electrode in corresponding 
conducting areas and total current per unit length in z-direction along the cut-
line 
Domain 
Current per unit length in z-direction, 
A/m 
1 1.41 
2 4.45 
3 1.41 
Along the cut -line 7.27 
 
The extreme cases of this research are: all cholesterol particles are arranged in 
parallel with current lines or perpendicular to it. As it is hard to calculate those 
cases manually, when cholesterol is arranged in particles, further simplifications 
are made. Cholesterol total area is recalculated in such way that it forms a 
rectangle one side of which is equal to 5mm.  
For all the cases frequency is chosen to be zero as it is in good agreement with 
model assumptions made and impedance turns into resistance. 
Rectangle blocks. Connection in series 
In case of perpendicular placement, the system can be represented by 3 
impedance elements connected in series (Figure 4.2–13). The FEM geometry 
for numerical simulation on this case can be observed in Figure 4.2–14. 
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Figure 4.2–13. Analytical representation of a system (series) 
 
Figure 4.2–14. Practical FEM implementation of a system (series) 
 
In that situation equivalent resistance is calculated analytically as a sum of 
three. 
Rୣ୯݀ = ʹRଶ + Rଵ݀  (4.2-2) I݀ = VdRୣ୯ = Ͳ.͹ A/m (4.2-3) 
 
 
Value of current calculated with FEM in this situation was IFEM=0.79 A/m. 
Calculated value exceeds theoretical value by 12%.   
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Rectangle blocks. Parallel connection 
Analytical and FEM formulation for this case are presented in Figure 4.2–15 
Figure 4.2–16 respectively. 
 
Figure 4.2–15. Analytical representation of a system (parallel) 
 
Figure 4.2–16. Practical FEM implementation of a system (parallel) 
 
For parallel resistance case, the equation for equivalent resistance will be 
(taking into account that in our case R1 = R3: 
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Rୣ୯݀ = ( RଵRଶʹRଶ + Rଵ) ͳ݀ (4.2-4) I݀ = VdRୣ୯ = Ͷ.ͷͺ A/m (4.2-5) 
 
 
IFEM=4.59 A/m. For this case, simulation result exceeds theoretical value by 
0.2%.  This study shows then in both cases, the simulation is in good 
agreement with theoretical results. In case of vertical cholesterol positioning it 
blocks a major part of current flowing through the system .This is why, even the 
small current that flows along the edge of geometry (simulation), results in 
difference between theoretical and FEM simulation results.   Horizontal 
positioning blocks just a small portion of current lines.  
Circular particles positioned in a line 
This simulation test shows the comparison of two extreme cases with similar 
conditions where rectangle is replaced with cholesterol particles set 
demonstrates decrease in current per unit length value in horizontal placement. 
This is believed to be related to the fact that current faces have bigger cross-
sectional area in that case than that of rectangular. The result for particles line 
positioned horizontally is shown in Figure 4.2–17. Picture represents geometry 
(above) and final computed current density plot (below).  
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Figure 4.2–17. Horizontal particles placement 
 
In case of vertical particle line, the value of current per unit length goes up as 
there is a possibility of current passing in between the particles. This is 
illustrated in Figure 4.2–18. 
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Figure 4.2–18 Vertical particle placement. 
This means that particle positioning will play the most important role in case of 
small number of particles in the area of interest.  
Comparison impedances for various cholesterol levels 
Assuming that all possible for now validations have been passed the new set of 
simulations has been performed. For total cholesterol values equal to 5 mmol/L 
and 3 mmol/L 500 files have been generated in attempt to represent real 
statistics of cholesterol distribution in blood plasma. Resulting histograms are 
presented in Figure 4.2–19. 
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Blue histogram is related to total cholesterol value of 3 mmol/L, orange 
represents total cholesterol of 5 mmol/L. Vertical axis reflects number of models 
with values (frequency) of results falling in related interval. Even though the 
difference between mean values does not exceed 3.2 % this graph gives clear 
evidence that impedance method (at least its 2D mathematical representation) 
can be used for cholesterol measurement. This graph has been created in first 
attempts to understand the whole idea of blood-cholesterol impedance. 
Further simulations led to a more efficient set of curves representing a 
dependence of the current density per unit length from total cholesterol level 
and number of cholesterol particles. The upper line is equivalent to total 
cholesterol of 3 mmol/L, middle one is 5 mmol/L, and the lower represents 
7mmol/L case (Figure 4.2–20).  
 
Figure 4.2–19. Values of current per unit length for total cholesterol levels 
 at 3 mmol/L and 5 mmol/L 
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Figure 4.2–20. Current per unit length as a function of total cholesterol and 
number of particles 
 
From the modelling point of view, strictly speaking the problem under 
investigation in this study is a truly 3D problem since a 2D problem domain 
cannot take into account the realistic geometry and material properties, the 
distribution of field and electrical parameters in the third dimension. This justifies 
the need for 3D FE modelling of the problem. 
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   Chapter 5. Modelling of Non-Invasive 
Cholesterol Measurement System in 3D 
5.1 Building a 3D model 
All assumptions used for 2D modelling are used in 3D. The first 3D model 
tested is similar to that of 2D being extended by 5 mm in third direction. Two 
more air domains added: one in front and one behind the central bit of the 
model (Figure 5.1–1). Material properties and boundary conditions for 3D case 
are present in Figure 5.1–2.  
The only difference is that in 3D case the fraction will be: 
ɀV = VV଴ = ʹ.͵Ͷ mmଷͳʹͷ mmଷ = Ͳ.Ͳͳͻ (5.1-1) 
 
 
This means that in the volume of interest the cholesterol particle will take only 
1.9% of the total volume of blood. Zoomed in central volume can be seen in 
Figure 5.1–3. The radius of that particle has already been calculated in (4.1-2). 
If that volume is divided between N small particles radius of each of them can 
be found as: 
rN = √ ͵ ∙ V଴Ͷ ∙ N ∙ Ɏయ  (5.1-2) 
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Mesh quality in 3D: 
q = ͹ʹ√͵Vሺhଵଶ + hଶଶ + hଷଶ + hସଶ + hହଶ + h଺ଶሻଷ ଶ⁄  
Again the criteria for 3D mesh is that element quality should be kept no less 
than 0.015. Average quality is kept above 0.8 (Figure 5.1–4, Figure 5.1–5, 
Figure 5.1–6) and, although they might not have a massive influence on overall 
solution, no inverted elements should be found within geometry [83]. The 
procedure of model building can be found presented in details in Appendix 3.  
 
 
Figure 5.1–1. 3D FE model of the cholesterol measurement system 
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Figure 5.1–2. 3D Model with boundary conditions 
 
 
 
Figure 5.1–3. 3D Model (zoomed in to show details of the electrode-particle 
assembly) 
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Figure 5.1–4. 3D custom mesh for 8 particles 
 
Figure 5.1–5. Quality of the external custom mesh in 3D case 
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Figure 5.1–6 Quality of the external particle custom mesh in 3D case. 
Mesh convergence study has been done, as well as two more types of 
meshing. Adoptive mesh study only led to significant increase in the time of 
solution (from 20 minutes to 2 days). Quadratic mesh also did not influence the 
solution by more than 0.1%. 
5.2 Results of 3D modelling and discussions 
In this section the complete set of analysis described above has been 
performed for a 3D case. Predefined extra fine mesh has been selected as a 
most appropriate according to mesh convergence analysis. 
The analysis of a total current as a function of number of particles was 
performed and results are displayed in Figure 5.2–1. 
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Figure 5.2–1. Current versus number of particles for 3D case 
 
This graph shows that increase in the number of particles does lead current 
curve to a plateau.  
The following investigation has been performed and the graph, representing 
current as a function of frequency has been evaluated (Figure 5.2–2). This 
graph highlights the problem that we are facing in 3D. The difference between 
current values without particles and current values with cholesterol presented is 
smaller than methods error.  
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Figure 5.2–2. Total current versus frequency for 3D case 
 
This highlights a doubt whether this is a result of incorrect modelling or the 
problem connected with a model of a system itself. Again a theoretical 
validation of obtained numerical results has been performed. 
5.2.1  Validation of 3D model from simplistic analytical 
solution 
One cubic volume conductor 
First result to be checked is a current when all of the volume but a central cube 
is assigned with air properties and central cube has got saline solution 
properties. In this case, total current can be calculated via: 
I = VR = VσAl = ʹͷ.ͳ݉� (5.2-1) 
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This is in agreement with that obtained by FE modelling from COMSOL 
solution, ICOMSOL= 25.13 mA. Results difference is 0.1%. This is because that is 
a model of ideal capacitor and field lines are not leaving volume of interest. This 
also gives a brief view on how fringe field effects (see below) influence the 
current and hence the impedance of our system. 
Parallel cylinders 
Any of 2D model results can be simulated in 3D by extrusion of a 2D model in 
third direction. So that for example current values in 3D are supposed to be 
equal to those in 2D multiplied by size of the volume of interest in third direction: 
ܫଷ஽ = (݀ܫ)ଶ஽ ݀ (5.2-2) 
 
 
So the 2D model with particles positioned vertically/ horizontally converts into 
3D model with cylinders positioned the same way. The geometrical 
representation is demonstrated in Figure 5.2–3.The current values are 
presented in Table 5.1. As expected, vertical line of cylinders blocks certain 
amount of current lines. 
Spherical particles arranged in a line 
In case of spheres, current has an additional possibility to go around the 
particles in third dimension, that fact explains increase in current values. 
Spheres arrangement is shown in Figure 5.2–4.The values of the current for 
those cases are presented in Table 5.1. 
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Figure 5.2–3. Horizontal and vertical lines of cylinders 
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Figure 5.2–4. Horizontal and vertical arrangement of spheres 
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Table 5.1. Current values depending on cylinder/particle positioning 
I, mA 2D->3D cylinders 3D cylinders 3D spheres 
Horizontal line 30.7 29.6 32.0 
Vertical line 23.0 22.8 32.4 
The first column of current values was recalculated from 2D results. For line of 
circles current value per unit length in z-direction were multiplied by length of z-
direction of the model, giving 5 mm cylinders as on Figure 5.2–3. Values for 
second and third column were obtained directly from 3D simulations of particle 
arrangements illustrated on Figure 5.2–3 and Figure 5.2–4. Values for 3D 
simulation of cylinders sets are lower than recalculated from 2D simulations 
(3.5% for horizontal orientation and 1% for vertical).  As expected for set of 
spheres they are significantly higher (8% for horizontal and 42% for vertical 
orientation). This can be attributed to excessive current paths that appear when 
cylinders are swapped for spheres.  
5.2.2 Additional analyses 
As results show there is no evidence that computation has calculated incorrect 
solution.  
More analyses have been performed, such as establishing the link between 
current and electric field. 
Case without particles 
When there is no particle in the volume the electric field on the plane, which 
crosses the total volume approximately in centre (cut-plane going through the 
centre is shown in Figure 5.2–5) should be uniform in the electrode area and its 
value is proportional to current value. Results are demonstrating the correct 
behaviour (Figure 5.2–6)  
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The current density, which is calculated along cut line (the position of the line is 
shown in Figure 5.2–7) is demonstrated in Figure 5.2–8. The total agreement 
with theory can be observed as the current density forms almost perfect step 
with the computed value to be exactly equal to analytical one calculated with 
Ohm’s law: 
j = σE = ͻ͹͸.ͺ A/mଶ (5.2-3) 
 
 
 
Figure 5.2–5. YZ-Cut plane 
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Figure 5.2–6. Electric field distribution on the cut-plane for the case with no 
particles 
 
Figure 5.2–7. Position of the central line on the cut-plane 
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Figure 5.2–8. Current density for the model with no particles 
Case with 1 particle in the middle 
The geometry and cut-pane together with the central line where the current 
density is evaluated is presented in Figure 5.2–9. 
Electric field distribution plot for this case is demonstrated in Figure 5.2–10, and 
current density plot along the central line is plotted in Figure 5.2–11 
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Figure 5.2–9. Geometry and central line for the case with 1 particle 
 
Figure 5.2–10. Electric field distribution for the case with 1 particle 
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Figure 5.2–11. Current density plot along the central line 
Analytical calculations for one particle in the middle can be performed and give 
the following current density values: 
c) For plasma on the edge of particle-plasma system: 
j = σE = ͳͶʹͷ.͸ A/mଶ (5.2-4) 
 
 
d) For particle: 
j௕ = σ௕E = ʹͲ A/mଶ (5.2-5) 
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This means that the developed mathematical model works and is in good 
agreement with theoretical and predicted results.  
A fresh look at a fringing shows that it counts for as much as 50 % of total 
current in our system.  
Total current has been calculated in yz-plane that goes through the middle of 
the volume of interest (Figure 5.2–12).Total current through this plane is 
computed as a sum of currents through conducting volumes I1, I2, I3. Using 
COMSOL results the following Table 5.2 has been evaluated. It gives:  
ܫ௧௢௧ − ܫଶܫ௧௢௧ ∗ ͳͲͲ% ≅ ͶͲ% (5.2-6) 
 
 
This together with other obtained results leads to the idea that our model, and 
hence our system, needs to be redesigned taking into account all the weak 
points.  
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Figure 5.2–12. Cross-section of the volume with yz-plane 
 
Table 5.2. Current through the corresponding conducting volumes and total 
current through cut-plane 
Domain I, mA 
1  7.31 
2 22.34 
3 7.3 
Whole cut –plane 36.95 
5.2.3 Comparison of impedances for different cholesterol 
levels in 3D 
Assuming that all necessary validations tests have been done the new set of 
simulations has been performed. For total cholesterol values equal to 7 mmol/l 
5 mmol/l and 3 mmol/l  set of curves representing  dependence of the current 
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density from total cholesterol level and number of cholesterol particles. The 
upper line is equivalent to total cholesterol of 3 mmol/L, middle one is 5 mmol/L, 
and the lower represents 7mmol/L case (Figure 5.2–13). 
 
 
 
Figure 5.2–13. Current as a function of total cholesterol and number of particles 
The difference between the current values is about 1.5 %. Although it is a small 
value, curves clearly show that for all studied models current values and there 
standard deviation fall within separate bands. 
This set of curves confirms hypothesis that impedance can be used to 
distinguish two close cholesterol levels in blood.  
These encouraging results mean that there is a reason to complicate used 
model even more by adding different type of blood particles. In next chapter red 
blood cells are added to add further complexity to COMSOL model.
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   Chapter 6. Introduction of Red Blood 
Cells 
6.1 Modelling investigations with RBC  
6.1.1 RBC and their electrical properties  
As mentioned before blood does not only contain plasma and cholesterol. On 
average, as much as 45% of total blood volume is occupied by blood cells. 
They can be divided into three main types:  red blood cells (RBC or 
erythrocytes), white blood cells (WBC) and platelets.  
RBC represent the major component of blood cells and account for as much as 
or more than 99% of the blood cells volume [67], [105]. A typical erythrocyte is a 
disk with diameter of approximately 6.2–8.2 µm [106]   and its thickness varies 
from 2–2.5 µm at the thickest part and to about 0.8–1 µm, which is a minimum 
thickness in the centre of a cell. They  have an average volume of about 90 fl 
[107] and their surface is about 136 μm2, and in solutions of lower osmotic 
pressure can swell up to a sphere shape containing 150 fl, without membrane 
distension. If the osmotic pressure falls below 0.5% saline, lysis is complete in 
0.35% [91].  
The primary function of erythrocytes is carrying haemoglobin, type of protein 
that deliveries oxygen from respiratory organs to the rest of the body and takes 
away carbon dioxide [108].   Their secondary functions include taking part in 
vessel wall relaxation process in case of oxygen deficiency [109], [110]; 
synthesis of nitric oxide, that contributes to regulation of vascular tonus [111];  
and release of free radicals, that kills pathogen cells by braking its membrane 
(immune function) [112], [113].      
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The other peculiar thing is that erythrocyte width is on average about 25% 
larger than capillary diameter, and there is a hypotheses that it is due to  
improvement of  the oxygen transfer from erythrocytes to tissues [114]. 
However, as with the biconcave shape this is not taken into account in the 
proposed model. 
The volume percentage of erythrocytes in human blood is called haematocrit.  It 
varies from 38% to 46% in adult women and form 42% to 54% in adult males 
[115].  
On average adult male has roughly 4.3 - 5.7 × 1012  RBC/l  and adult woman 
has about 3.9 – 5.0 RBC/l at any given time, comprising approximately one 
quarter of the total human body cell number. For comparison, for white blood 
counts this number is 4.0 – 10.0 × 109  WBC/l  and for platelets 143 – 400× 109  
cells/l  [108].     
Electrical properties of RBC are approximation of results taken from [116] that 
correlate with values given in [117]. Typical current lines behaviour in biological 
cells depending on frequency is illustrated in Figure 6.1–1.  
At 50 kHz conductivity of RBC is assumed being equal to σr = 0.7 S/m and 
relative permittivity εrr = 79.  
 
Figure 6.1–1. Frequency dependence of current paths 
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6.1.2 Maximum percentage of RBC 
As dimensions of real RBC vary, there is a need to find the average values of 
diameter and height for modelling purposes.  According to [105] the average 
diameter is equal to 7.5 m. Average height is calculated from values given 
above using the assumption that erythrocytes are modelled as cylinders and not 
biconcave disks and is taken as an average between the maximum and 
minimum thickness, equal to 1.65 m. 
The particles are distributed randomly within the area of interest, using the 
same function that was utilized for cholesterol particles (Figure 6.1–2).   
 
Figure 6.1–2. RBC parallel to xy-plane 
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The main problem that has been encountered at that point was that it was not 
physically possible to model the real haematocrit. The highest volume 
percentage of erythrocytes that was reached did not exceed 40%. More than 
that, even for that percentage and number of particles above 150, it was not 
possible to implement truly random distribution, which would include random 
particle orientation. This partially was attributed to the mathematical method 
used for calculation of distances between the particles and repair tolerance 
values within COMSOL model. The main challenge was to create a method that 
would allow two particles to be in close contact and even touch, but not overlap. 
In the first models, it was done by introducing the sphere around every RBC, 
and has been changed to ellipsoid in later script files. Although this method is 
not ideal, it proved to work and allow reach the number of modelled particles, 
for which current curve reaches the plateau area, as it will be seen later in the 
thesis. This led to necessity for implementation of additional assumptions. 
6.2 Additional assumptions 
As decided, electrodes would be placed on the earlobe. This means further 
calculations of volume of the blood in an earlobe are required. To do that the 
total length of capillaries, total volume of blood on capillaries and blood 
compositions are needed. The density of capillary net in the earlobe is 
displayed in Figure 6.2–1. 
The blood vessels (arteries, capillaries, and veins), laid end-to-end, would 
measure about 100,000 km (60,000 miles), or approximately 2.5 times the 
circumference of the earth. Capillaries account for about 80,000 km (50,000 
miles) of vasculature in an adult [118]. 
From [119] the total volume of blood is 7 % of the total body weight or 70 ml/kg. 
This means that in an average person that weights 63 kg it gives: 
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௕ܸ = ݉ ∙ Ͳ.Ͳ͹ = Ͷ.Ͷͳ ݈ (6.2-1) 
 
 
 
   Although capillaries count for more than 50 % of total blood vessel length the 
total volume of blood in capillaries in accordance to [120] is equal to only 5 % of 
total blood volume. 
From that the total volume of blood in capillaries is  
 
௕ܸ௖௔௣ = ௕ܸ ∙ Ͳ.Ͳͷ = Ͳ.ʹʹͲͷ ݈ (6.2-2) 
 
 
 
The total volume of capillaries from  capillary radius  [91] and total length. The 
amount of blood per unit of capillaries or the fraction of volume taken by the 
blood would be a ratio of volume of blood in capillaries to the total volume of 
capillaries. 
௖ܸ௔௣ = ݈௖௔௣௧ ∙ ݎ௖௔௣ = ͳ.ͷ͹Ͳ ܮ (6.2-3) 
௕௖௔௣ = ௕ܸ௖௔௣௖ܸ௔௣ = Ͳ.ͳͶ  (6.2-4) 
 
 
The value can be expressed in decimal 0.14/l or as percentage – 14%  
To simplify the model we suggest that all of the earlobe volume is filled with 
capillaries. 
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Considering this assumption, we can get that an earlobe will contain the amount 
of blood per unit of capillaries multiplied by the total volume of earlobe (14% of 
the volume). 
If according to [115]  on average haematocrit in an adult is about 46%, then only 
6.44% of volume will be occupied by RBC in an earlobe. 
 
Figure 6.2–1. Capillaries in earlobe 
(Susumu Nishinaga) 
 
Although in stationary blood RBC are oriented randomly, they do tend to have 
predominant orientation due to the blood flow and it changes with each heart 
contraction. This will have a significant effect on blood impedance [103]. 
However, this problem would not arise when the measurements are done on 
the area with domination of capillaries. Due to their geometry, erythrocytes in 
capillaries are only able to travel in one direction. This domination of orientation 
can be seen in Figure 6.2–2. 
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Figure 6.2–2. Alveoli. 
Capillary net of an alveola 
showing the erythrocytes 
within the blood vessels 
(Oliver Meckes) 
 
 
      
6.3 3D realisation for earlobe proportions 
For modelling purposes, the ratio between height and diameter of RBC is kept 
close to realistic and as it is mentioned above, it is equal to 2.27. As already 
mentioned geometry is kept simple by RBC being modelled as cylinders, not 
oval biconcave disks [121]. The central part of the model is shown in Figure 
6.3–1.  
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Figure 6.3–1. Distribution of RBC  
 
The plateauing effect is also present for RBC and can be seen in Figure 6.3–2. 
As expected the much larger number of particles is needed for getting into the 
plateau area. It is also worth mentioning that for RBC dispersion of the current 
values is higher then for cholesterol, as there is a higher possibility af them 
getting accumulated in one spot because of higher concentration.   
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Figure 6.3–2. Variation of current with number of RBC, Nr  
Another set of numerical experiments has been performed to determine haw 
particle orientation influences the total impedance of the system. As it also 
involved cholesterol particles presence/absence, these results would be 
included below in the 6.4.  
6.4 Combination of RBC and cholesterol 
The further developed models get more complicated partially due to large 
fraction of RBC introduced in the area of interest. Although the contrast ratio for 
electrical properties of erythrocytes is nowhere near as high as of cholesterol, 
they will still play a key role in impedance change in comparison with pure 
plasma model. But this is not the only factor complicating the task of new 
system modelling. 
Recalculation of total blood volume would mean recalculation of total volume of 
cholesterol. For total cholesterol of 5 mmol/l the value will dramatically drop 
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from 1.87% to just 0.26%. This undoubtedly will cause extra complexity in 
detection of impedance input for close cholesterol levels. 
  
 
Figure 6.4–1. Distribution of RBC and cholesterol particles 
On top of all that, the major difference in sizes between erythrocytes and 
cholesterol particles makes meshing of the area of interest a challenging task. 
This is still supposed to be done more or less uniformly with no more than 20% 
increase in element size in between the two neighbouring elements. MathLab 
code used for particles placement is present in Appendix 5. 
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6.4.1 Results showing depedance of current on frequency and 
the orientation of RBC 
Theory suggests that up to 100 kHz RBC properties would not significantly 
change and there should not be any impact on total current and hence 
impedance of the system. This has been proven by numerical experiment. The 
results could be seen in Figure 6.4–2. 
 
Figure 6.4–2 Dependence of total current on the number of RBC Nr at different 
frequencies (RBC parallel to the electrode surface).  
Again, 10 models for each point on the curve were created to minimize particle 
distribution influence. 
The other question is linked to erythrocytes orientation. As it has been 
mentioned above, various sources suggest that there will be a change in 
impedance up to 2 – 4% [103] due to particle inclination in respect to electrode’s 
plane.  
It is obvious that resistivity of the system is maximum when cylinder bases are 
Introduction of Red Blood Cells 
 
108 
 
parallel to the electrode’s surface, and is minimum when particles are 
perpendicular to it.  
Two sets of computations have been produced. One for RBC with θ= 00 (parallel 
to electrodes) and tilted by θ= - 450 (Figure 6.4–3).  
 
Figure 6.4–3 Distribution of cholesterol and RBC, tilted by θ = - 450.   
There was a doubt that dispersion of results for a fixed number of RBC (Nr < 
500) was due to discretization error. Additional analysis has been performed to 
give understanding if that was a case. The following results in Figure 6.4–4 and 
Figure 6.4–5 suggest that meshing quality is stable enough and discretization 
does not play a key role in case of θ = 00, however for θ = - 450 coarser mesh 
seems to have an impact on some of the models. For both cases results more 
or less simultaneously shift up, that looks like as if they were just moving closer 
to accurate solution. 
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Figure 6.4–4. Dependence of current on mesh for θ= 00 
 
 
Figure 6.4–5. Dependence of current on mesh for θ= - 450 
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This analysis allowed concluding that for RBC orientation has a higher influence 
on system impedance than particle distribution (dispersion on the graph). Two 
curves for this study are shown in Figure 6.4–6. 
 
Figure 6.4–6. Dependence of current on the orientation of RBC 
Some further analysis gives more details on how RBC orientation influences 
total current (Table 6.1). This study was aimed at seeing how current on the 
electrode and, therefore, impedance would change due to RBC being parallel to 
main planes of the coordinate system. This included 10 models with number of 
erythrocytes Nr =1500 and number of cholesterol particles Nc = 500. This 
involved performing 4 sets of simulations: with cholesterol particles, with RBC, 
with mixture of both and with no particles present in the area of interest. To 
exclude mesh dependence, all of the simulations had the same mesh and 
instead of exclusion of particles, there properties are changed to those of blood 
base.  Results were put in Table 6.1.  
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Table 6.1. Current values for different RBC orientation (with and without 
cholesterol) 
mixture type 
RBC 
orientation 
I, mA 
RBC+ 
cholesterol 
RBC cholesterol Empty 
||| (YZ - plane) 31.85705 31.88651 33.67016 33.72772 
|o| (XZ – 
plane) 
32.21244 32.24641 33.65765 33.71294 
|-| (XY – plane) 32.34572 32.36892 33.69326 33.75665 
For presented research impedance change due to inclination varies from 0.7% 
for θ= - 450 to 1.5% for θ= - 900. For XZ orientation change in current value is in 
between the two other positioning and is equal to 1.1%. 
Due to volume recalculation, cholesterol input in impedance change is getting 
less and less obvious and gets to the point of being of a same order as methods 
error (0.1%).  
Frequency dependence has been tested for the tilted RBC study as well and it 
shows no significant influence of frequency change in the band up to 100 kHz, 
this is presented in Figure 6.4–7. This is expected and it agrees with research 
and modelling results published by other research groups. 
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Figure 6.4–7. Dependence of current on frequency for tilted RBC 
As expected, in this case RBC input in impedance will be higher, although the 
contrast ratio for electric properties is smaller. This means that despite of 
conductivity being of the same order the fact that erythrocytes occupy 
considerable part of the volume has a significant effect on electrical behaviour 
of the system.     
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6.4.2 Dependence of the current curve on the number of 
cholesterol particles  
Although it has been proven in 5.2.3 that for Nc higher than 100 the change in 
solution is of the same order as global error of simulations, the decision has 
been made to test the same hypothesis for the mixture of erythrocytes and 
cholesterol. Results are shown in Figure 6.4–8. 
 
Figure 6.4–8. Dependence of current on number of RBC, Nr; Nc= const 
Although the change in current value is again of the same order as solutoin 
tollerance, it is preferable to finish the last set of simulations with Nc equal to 
500 particles. 
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6.4.3 Dependence of the current curve on total cholesterol 
levels 
The final stage of current analysis was to see how total current and hence 
impedance of the system would change according to different cholesterol levels. 
Results can be seen in Figure 6.4–9. As predicted, there is a visible difference 
in current that depends on cholesterol concentration. At the same time, there is 
a significant overlapping in dispersion for neighbouring TC levels.  
 
Figure 6.4–9. Dependence of total current for different cholesterol levels  
It is very hard to judge if obtained results are what they are supposed to be as 
the difference between any two close levels is not equal in terms of volume. So 
more of simulations have been carried out.  This has been done for total 
cholesterol levels of 1, 2, 4 and 8 mmol/l and fixed number of erythrocytes and 
cholesterol particles, that is equal to 1500 and 500 respectivly. In that case 
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values of current and hence impedance should be equidistant. Figure 6.4–10 
illustrates this fact.  
 
Figure 6.4–10. Values of current for total cholesterol concentrations 1, 2, 4, and 
8 mmol/l  
Dynamics of mean current value decrease with increase in total cholesterol 
level is shown in Figure 6.4–11. 
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Figure 6.4–11. Average values of current for different cholesterol levels  
As expected, there is a steady decrease in current level with increase of total 
volume, occupied by cholesterol. These results confirm that electrical 
impedance of blood is a quantity that can be used to determine cholesterol 
levels in human blood. 
There was no experiment set to mimic mathematical model present in this 
research. And although RBC related results are in good agreement with 
modelling and experimental results obtained elsewhere (see 6.3), there were 
still concerns about the way electrodes were modelled.  
As explained in Chapter 4 and Chapter 5, electrodes were modelled as hollows 
to avoid necessity of choosing electrode material at that stage.  
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   Chapter 7. Validation of some of the FE 
modelling results against simple 
experimental data 
In order to validate the modelling methodology for electrode modelling 
developed in this work some of the experiments conducted on blood 
conductivity at City University London were simulated and the results 
compared. In the experimental study, a 4-electrode system was used in which 
four electrodes were placed side by side on a non-conducting base plate and 
immersed in the blood (horse blood) volume to be measured. The two outer 
acted as the ‘driving electrodes’ (to which voltage was applied) and the 
impedance was measured between the two inner electrodes (‘measuring 
electrodes’). 
 Some of the experimental studies conducted using the above set up was 
simulated using the FE models developed in this work shown in Figure 7–1 (a) 
and (b). Here the electrodes are positioned 1 mm apart, have a depth, a = 0.1 
mm, height, h = 10 mm and width, b = 0.5 mm. 
 
Figure 7–1 (a) computational model of the experimental set-up and (b) details of 
electrode placement. 
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All of the outside boundaries are given potential φ = 0, and placed far enough 
so that they do not affect the field lines nearer to the electrodes. Outer 
electrodes were set potential φ = ± 5 V. In addition, inner electrodes are 
assigned with floating potential.  
This is not a trivial problem since it has no straightforward analytical solution.   
To simplify the task an additional model was created which was similar to the 
experimental set up except for the electrodes which, unlike in the experimental 
set up were placed facing each other (rotated by 900). This can be seen in 
Figure 7–1. Here the electrodes are kept 1mm apart. 
 
Figure 7–2 (a) additional 3D model and (b) close-up showing details 
The first thing that needs to be checked is potential line distribution.  As there is 
no fixed potential on the inner electrodes, care should be taken.  Surface of 
each electrode should be equipotential surface and that can be done by 
assigning them with appropriate properties. This was done by choosing floating 
potentials.  Resulting potential line distribution can be seen in Figure 7–3. 
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Figure 7–3 Distribution of electric potential lines for electrodes placed facing 
each other 
The condition of equipotential surfaces is satisfied and this can be clearly seen 
along the cut line going through the centre of xz-plane (y=0). This is illustrated 
below (Figure 7–4). 
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Figure 7–4 Potential distribution along the cut-line (x=[-5,5], z=0). 
After that, current distribution is checked to see how it flows within the volume of 
interest (). 
 
Figure 7–5 Current distribution. 
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Once this has been done, impedance is calculated using material properties, 
electrode surface area and distance between the electrodes: 
ܼ௧ℎ௘௢௥ = ݀� ∙ � =  ʹͺͷ ܱℎ݉ (7-1) 
 
 
This result is compared with impedance value that can be calculated from 
potential and current values calculated with COMSOL: 
ܼ = ܸܫ =  ʹ.ͳ͹ͺ ܸͺ.͸͹ ݉� = ʹͷͳ ܱℎ݉ (7-2) 
 
 
The theoretical value of impedance exceeds computed by 13.5%. This 
difference can be attributed to it being a 3D problem. 
As results are comparable, the initial model is now considered. Same set of 
graphs is printed for that model (Figure 7–6, Figure 7–7, Figure 7–8). 
 
Figure 7–6 Potential distribution between the flat electrodes 
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Figure 7–7 Potential distribution along the cut-line for flat electrodes 
 
Figure 7–8 Current distribution for flat electrode positioning. 
However, calculation of impedance in this study is tricky because potential 
difference on the driving electrodes will have a significant input into impedance 
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of the system. To measure this contributes a perpendicular plane has been put 
in the system. It is representing the plane, current flows through (Figure 7–9). 
 
Figure 7–9 Cut plane for flat electrode positioning 
When driving electrodes are assigned with potential, resulting current through 
the cut plane is I = 11.9 mA. Potential on measuring electrodes is then equal to 
φ = ± 0.951 V 
When the driving electrodes kept at φ = 0 (Figure 7–10, Figure 7–11) and 
driving electrodes are assigned with potential found from previous model, total 
current through the plane is I = 7.33 mA. 
 
Figure 7–10 Potential distribution for flat electrode positioning, driving 
electrodes switched off. 
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Figure 7–11 Potential lines for flat electrode positioning with switched off 
electrodes. 
This gives resulting impedance Z = 259 Ohm. This is comparable with 
experimental results Zexp = 250 Ohm. The difference does not exceed 3.6%. 
This proves that methodology used for electrode modelling gives correct results 
and can be used for future modelling. This can be done not only within this 
research, but also in other studies where electrode material is not known. 
This completes the set of tests that where undertaken in current research 
project, which summarizes most important physical and electrical parameters 
and effects, which determine and influence behaviour of experimental system.  
At that point, conclusions and further work can be summed up. 
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   Chapter 8. Conclusions and further 
work 
8.1 Conclusions 
The possibility and the need for creation of a non-invasive cholesterol 
measurement device have been discussed. Impedance was taken as a 
parameter to be measured. As a result of this research, methodologies for 
human blood modelling and electrode modelling were developed. Tested and 
validated where possible.  
The following aims with corresponding objectives have been achieved. 
Aim 1 Justify necessity of new method for cholesterol level measurement. This 
included: 
a) Analysis of all existing methods. It was done in Chapter 1. This 
included highlighting their advantages and disadvantages.  
b) In depth understanding of current routine test process. This included 
detailed studies of biochemistry books on current blood test methods. 
It also included visit to biochemistry lab at Whittington Hospital 
(Whittington Health NHS, London)    
c) Sought clinician’s opinion on proposed method. Opinion was sought 
from biochemistry lab staff, medical students, midwife and a GP. All 
of them concluded that proposed method would ease their work, by 
minimizing possibility of human error and time needed for obtaining 
test results. 
Aim 2 Development of appropriate methodologies for mathematical modelling 
and simulation of penetration of electric field and distribution of electric 
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current and potential in living tissues. This was linked with following 
objectives: 
a) Develop 2D realistic finite element (FE) models.  Development of 
appropriate methodologies for mathematical modelling and 
simulation of penetration of electric field and distribution of electric 
current and potential in living tissues has been done. 
b) Develop 3D realistic finite element (FE) models.  Same 
methodologies have been used for 3D modelling. For 3D models 
effect of fringing has been quantified. As it is one of the main issues 
arising with two electrode system, it needs to be addressed in case 
experimental prototype will be made. 
Aim 3      Investigate the distribution of alternating currents and electric 
potential in developed FE models. This was achieved through the 
following objectives:  
a) Use various physiological properties  in FE models developed in 
Aim1 (a) and Aim1 (b). 2D simulations have shown that it is 
possible to distinguish between two close cholesterol levels values 
and that it is possible to model cholesterol as a set of associations 
of cholesterol molecules. 3D simulations have shown that 
although it is still possible to distinguish between two close 
cholesterol levels values, the difference gets significantly smaller 
(e.g. for TC 3 and 5 it decreases form 3% to 1.3%)  
b) Change of material properties. Further increase in complexity of 
the model (by introduction of red blood cells) makes differentiation 
even harder, as multiple effects related to them occur (such as 
orientation and concentration dependence). 
c) Change of electrical parameters. Frequency analysis has shown 
that for proposed frequencies, changes in current value are not 
dependant on frequency.  
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Aim 4     Establish functional relationship between calculated currents on 
measuring electrodes (hence impedance values) and concentration of 
cholesterol in the blood. Objective related to this aim is:   
a) For a given voltage drop, this is done by advanced biomedical signal 
processing of potential signals calculated by FE modelling. It has 
been proven that in all cases current is a quantity to be measured as 
it gives the impedance of the system because there is a linear 
relation between voltage, current and impedance 
Nevertheless, modelling results conducted in this work have shown that it is 
possible to discriminate total cholesterol levels in human blood ranging from 1 
to 9 mmol/L by impedance technique. 
 
8.2 Contribution to the original work 
Methodologies developed in this research can be used in other fields involving 
electromagnetic simulations. 
Particle coagulation technique can successfully replace effective conductivity 
modelling method. It can be used in electromagnetic simulations of less 
conductive particles suspended in conductive solvent. It was proven that this 
methodology works in cases where conductivity ratio solv/part > 2 and simplifies 
system significantly for ratio >70. It was also tested on modelling of non-
spherical particles and has been proven to work well in case of all particles 
having the same incline angle.  
The other technique that was used in this research allows simplifying electrode 
modelling. Electrodes were modelled as hollows. This means there is no need 
to choose specific electrode material. It also helps to overcome problem some 
of the software faces while modelling metal electrodes. 
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8.3 Further work 
Although blood models at this stage include only two types of particles, 
nevertheless the methodologies developed in this work can simulate human 
blood taking into account its major component, the RBC. The analyses reported 
here represent two extreme cases.  One of them is suspension of small 
quantities of non-conductive particles (cholesterol) with high electric properties 
contrast ratio. The other one is focused on large quantities of particles with 
smaller contrast ratio (RBC). There is a need to make it more complicated by 
adding components that have small contrast ratio and are present in small 
quantities in the blood (such as WBC, under 1%) and performing further 
frequency analysis to find out what effect do other components of the realistic 
blood system have on the impedance of our system (such as other types of 
blood cells, skin, skin-electrode contact gel). 
Despite of the fact that all of the electric parameters for modelling have been 
taken from experimental data obtained by other research groups, the main 
problem is that there is no agreement on one set of values and a whole range of 
values can be found in literature. So to get more realistic results an 
experimental validation is still needed with parameters of separate components 
that can be measured in the lab and then put together in a mixture, for which 
computational modelling is made.  
As the field spreads outside of the volume of interest impedance will be 
influenced not only by cholesterol particles inside but on the outside as well, 
quantification of this effect needs to be done alongside with experimental 
validation. 
And finally yet importantly, the effect of cholesterol deposed in the skin (used by 
PreVu diagnostic system) on total impedance of the system needs to be 
quantified.  
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Appendix 1. Calculation of total volume of 
cholesterol in a given volume of blood for 
given total cholesterol level  
The simplest way to calculate the volume of cholesterol in 1 mm3 is by using the 
density  of cholesterol (ߩ௖ℎ௢௟ = ͳ.Ͳ͵ ௚௖௠య) and its molar weight (ܯ ௖ܹℎ௢௟ = ͵.ͺ͹ ∗ͳͲଶ ௚௠௢௟) [122]. The volume of 1 mole of cholesterol will then be: 
௠ܸ௢௟ ௢௙ ௖ℎ௢௟ = ܯܹߩ = ͵.ͺ͹ ∗ ͳͲଶ ݃݉݋݈ͳ.Ͳ͵ ݃ܿ݉ଷ = ͵.͹ͷ͹ ∗ ͳͲହ ݉݉ଷ/݉݋݈ (A1-1) 
 
 
From the definition of molar weight then volume of one cholesterol particle is: 
௖ܸℎ௢௟ ௣௔௥௧ = ௠ܸ௢௟ ௢௙ ௖ℎ௢௟�ܰ = ͵.͹ͷ ∗ ͳͲହ݉݉ଷ݉݋݈͸.Ͳʹʹ ∗ ͳͲଶଷ  ݌ܽݎݐ݉݋݈ = Ͳ.͸ʹʹ ∗ ͳͲ−ଵ଼ ݉݉ଷ (A1-1) 
 
 
Knowing the quantity of total cholesterol (ߥ்௢௧௖ℎ௢௟ = ͷ ݉݉݋݈/ܮ) can find the 
volume of cholesterol in 1 mm3: 
௖ܸℎ௢௟ ௜௡ ଵ ௠௠య  = ௠ܸ௢௟ ௢௙ ௖ℎ௢௟ ∗ ߥ்௢௧௖ℎ௢௟ =  
= ቆ͵.͹ͷ ∗ ͳͲହ ݉݉ଷ݉݋݈ ቇ ∗ (ͷ ∗ ͳͲ−଼ ݉݋݈݉݉ଷ) = (A1-3) = ͳ.ͺ͹ ∗ ͳͲ−ଶ ݉݉ଷ   
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Appendix 2. Software procedures for 
building 2D finite element models 
In 2D model building looks as following 
GEOMETRY1 
 In the Model Builder window, select  Model 1>Geometry 1 and change length 
unit to mm.  
Block 1 
Right-click on Geometry 1 and select Square, modify Side length to 5, 
Position>Centre (x, y as 0).   
Rectangle 1 
In the Model Builder window, right-click Geometry and choose Rectangle. 
Choose rectangle settings. Locate the Size section. In the Width edit field, type 
14.5. In the Height field, type 5. Locate the Position section. Select Base 
corner. In the x edit field, type -17.5. And in the y field put -2.5. Click the Build 
Selected button. 
Rectangle 2 
In the Model Builder window, right-click Geometry and choose Rectangle. 
Choose rectangle settings. Locate the Size section. In the Width edit field, type 
15. In the Height field, type 7.5. Locate the Position section. Select Base 
corner. In the x edit field, type -17.5. And in the y field put -10. Click the Build 
Selected button. 
Rectangle 3 
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In the Model Builder window, right-click Geometry and choose Rectangle. 
Choose rectangle settings. Locate the Size section. In the Width edit field, type 
15. In the Height field, type 7. 5. Locate the Position section. Select Base 
corner. In the x edit field, type -17.5. And in the y field put -2.5. Click the Build 
Selected button. 
Rectangle 4 
In the Model Builder window, right-click Geometry and choose Rectangle. 
Choose rectangle settings. Locate the Size section. In the Width edit field, type 
5. In the Height field, type 7. 5. Locate the Position section. Select Base 
corner. In the x edit field, type -2.5. And in the y field put -2.5. Click the Build 
Selected button. 
Rectangle 5 
In the Model Builder window, right-click Geometry and choose Rectangle. 
Choose rectangle settings. Locate the Size section. In the Width edit field, type 
5. In the Height field, type 7. 5. Locate the Position section. Select Base 
corner. In the x edit field, type -2.5. And in the y field put -10. Click the Build 
Selected button. 
Mirror 1 
In the Model Builder window, right-click Geometry > Transforms and choose 
Mirror. Choose mirror settings. Tick the Keep input objects and put into Point 
on Line of Reflection zeros. Click the Build Selected button. 
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Figure A2-8.3–1 Basic model in 2D. 
MAGNETIC AND ELECTRIC FIELDS 
Ground1 
In the Model Builder window, right-click Magnetic and Electric Fields > 
Magnetic Insulation 1 and choose Ground 1. Select all outside boundaries. 
Electric potential 1 
In the Model Builder window, right-click Magnetic and Electric Fields > 
Magnetic Insulation 1 and choose Electric Potential. Select boundaries 8, 9, 
10, 13 and put Electric potential1 value V0 -1.428. In this model electrodes are 
modelled as hollows, so that is why potential is applied on all four boundaries. 
Electric potential 2 
In the Model Builder window, right-click Magnetic and Electric Fields > 
Magnetic Insulation 1 and choose Electric Potential. Select boundaries 
20,21,23,25 and put Electric potential2 value V0  1.428.  
Appendices 
 
148 
 
MESH1 
In the Model Builder window, click Model 1>Mesh 1. Go to the Settings 
window for Mesh. Locate the Mesh Settings section.  Select User-controlled 
mesh in Sequence type. Right-clock on Mesh 1, change Element size to 
custom, Element size parameters set as 0.5 for Maximum element size and 
0,05 for Minimum element size. 
 
Figure A2-8.3–2 Mesh for 2D geometry. 
STUDY 1 
In the Model Builder window, select Study 1 > Step 1: Frequency Domain. In 
frequency domain settings put 50000 in Frequencies field. Right-click Study 1 
and choose Compute. 
RESULTS 
Right-click on Results and select 2D Plot Group. Right-click on 2D Plot Group 
1, select Surface 1 and choose electric potential (V) in Expression. 
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Figure A2-8.3–3 Electric potential in 2D basic model. 
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Appendix 3. Software procedures for 
building 3D finite element models 
In 3D geometry building looks as following 
GEOMETRY1 
 In the Model Builder window, select  Model 1>Geometry 1 and change length 
unit to mm.  
Block 1 
Right-click on Geometry 1 and select Block, modify Width, Depth and Hight 
changing to 5, Position>Centre (x, y, z as 0).   
Work Plane 1 
In the Model Builder window, right-click Model 1>Geometry 1 and choose 
Work Plane. Go to Settings, locate plane as xz-plane and put y-coordinate as 
-2.5. Click the Build Selected button. 
Rectangle 1 
In the Model Builder window, right-click Geometry and choose Rectangle. 
Choose rectangle settings. Locate the Size section. In the Width edit field, type 
14.5. In the Height field, type 5. Locate the Position section. Select Base 
corner. In the x edit field, type -17.5. And in the y field put -2.5. Click the Build 
Selected button. 
Rectangle 2 
In the Model Builder window, right-click Geometry and choose Rectangle. 
Choose rectangle settings. Locate the Size section. In the Width edit field, type 
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15. In the Height field, type 7.5. Locate the Position section. Select Base 
corner. In the x edit field, type -17.5. And in the y field put -10. Click the Build 
Selected button. 
Rectangle 3 
In the Model Builder window, right-click Geometry and choose Rectangle. 
Choose rectangle settings. Locate the Size section. In the Width edit field, type 
15. In the Height field, type 7. 5. Locate the Position section. Select Base 
corner. In the x edit field, type -17.5. And in the y field put -2.5. Click the Build 
Selected button. 
Rectangle 4 
In the Model Builder window, right-click Geometry and choose Rectangle. 
Choose rectangle settings. Locate the Size section. In the Width edit field, type 
5. In the Height field, type 7. 5. Locate the Position section. Select Base 
corner. In the x edit field, type -2.5. And in the y field put -2.5. Click the Build 
Selected button. 
Rectangle 5 
In the Model Builder window, right-click Geometry and choose Rectangle. 
Choose rectangle settings. Locate the Size section. In the Width edit field, type 
5. In the Height field, type 7. 5. Locate the Position section. Select Base 
corner. In the x edit field, type -2.5. And in the y field put -10. Click the Build 
Selected button. 
Mirror 1 
In the Model Builder window, right-click Geometry > Transforms and choose 
Mirror. Choose mirror settings. Tick the Keep input objects and put into Point 
on Line of Reflection zeros. Click the Build Selected button. 
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Figure A3-8.3–1 Work plane 1. 
 
Extrude 1 
Right-click on the Work Plane 1 and select Extrude. In extrude settings tick the 
Keep cross-sectional faces and Reverse directions and put 5 into Distances 
field. Click the Build Selected button. 
Work Plane 2 
In the Model Builder window, right-click Model 1>Geometry 1 and choose 
Work Plane. Go to Settings, locate plane as xz-plane and put y-coordinate as 
-17.5. Click the Build Selected button. 
Rectangle 1 
In the Model Builder window, right-click Geometry and choose Rectangle. 
Choose rectangle settings. Locate the Size section. In the Width edit field, type 
35. In the Height field, type 20. Locate the Position section. Select Base 
corner. In the x edit field, type -17.5. And in the y field put -10. Click the Build 
Selected button. 
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Extrude 2 
Right-click on the Work Plane 1 and select Extrude. In extrude settings tick the 
Keep cross-sectional faces and Reverse directions and put 15 into 
Distances field. Click the Build Selected button. 
Work Plane 3 
In the Model Builder window, right-click Model 1>Geometry 1 and choose 
Work Plane. Go to Settings, locate plane as xz-plane and put y-coordinate as 
17.5. Click the Build Selected button. 
Rectangle 1 
In the Model Builder window, right-click Geometry and choose Rectangle. 
Choose rectangle settings. Locate the Size section. In the Width edit field, type 
35. In the Height field, type 20. Locate the Position section. Select Base 
corner. In the x edit field, type -17.5. And in the y field put -10. Click the Build 
Selected button. 
Extrude 2 
Right-click on the Work Plane 1 and select Extrude. In extrude settings tick the 
Keep cross-sectional faces and put 15 into Distances field. Click the Build 
Selected button. 
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Figure A3-8.3–2 Geometry. 
MAGNETIC AND ELECTRIC FIELDS 
Electric potential 1 
In the Model Builder window, right-click Magnetic and Electric Fields > 
Magnetic Insulation 1 and choose Electric Potential. Select boundaries 22-
26, 30 and put Electric potential value V0 1.428. In this model electrodes are 
modelled as hollows, so that is why potential is applied on all six boundaries. 
Electric potential 2 
In the Model Builder window, right-click Magnetic and Electric Fields > 
Magnetic Insulation 1 and choose Electric Potential. Select boundaries 43, 
44, 45, 48, 51, 53 and put Electric potential value V0 -1.428.  
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MESH1 
In the Model Builder window, click Model 1>Mesh 1. Go to the Settings 
window for Mesh. Locate the Mesh Settings section. From the Element size 
list, select Extra Fine. Click the Build All button. 
 
Figure A3-8.3–3. Mesh of main geometry. 
 
STUDY 1 
In the Model Builder window, select Study 1 > Step 1: Frequency Domain. In 
frequency domain settings put 50000 in Frequencies field. Right-click Study 1 
and choose Compute. 
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RESULTS 
To display electric field distribution in the middle of geometry it is necessary to 
build a cut-plane. For that go to Results > Data Sets and select Cut Plane. In 
settings put yz-plane and 0 in x-coordinate.  
 
Figure A3-8.3–4 Cut-plane 1, x=0. 
 
Right-click Results and select 2D Plot Group. In settings put Data set Cut 
Plane 1. Right-click on 2D Plot Group 1, select Surface and choose mef. 
normE in Expression. 
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Figure A3-8.3–5 2D Plot of electric field (cut-plane1). 
 
To display current density along the line, do Results > Data Sets and select 
Cut Line 3D.  In settings put y-coordinate for Point 1 -17.5 and 17.5 for  Point 
2, leaving all the others as 0. Plot it by pressing Plot button. 
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Figure A3-8.3–6 Cut Line 3D 1 
 
Right-click Results and select 1D Plot Group. In settings put Data set Cut 
Line3D 1. Right-click on 1D Plot Group 1, select Line Graph and choose mef. 
normJ in Expression. 
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Figure A3-8.3–7 Current density along cut line. 
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Appendix 4. MatLab scripts for random 
distribution of cholesterol particles in 3D 
finite element models  
function out = one_3D  
% 
% katia_init.m  
% 
% ==== COPYRIGHT EKATERINA ARISTOVICH ==== 
% 
% Model exported on Jan 31 2011, 22:35 by COMSOL 4.0.0.982. 
 RandStream.setDefaultStream ... 
     (RandStream('mt19937ar','seed',sum(100*clock))); 
  
  
Volume = 125; 
length = Volume^(1/3); 
TC=5; 
n_of_c= 125; 
 
CVIB=TC*3.75*0.001*Volume; 
R_of_one=(3*CVIB/(4*pi))^(1/3); 
% DS2=pi*R_of_one^2; 
  
 
import com.comsol.model.* 
import com.comsol.model.util.* 
File = fopen('C:\\Users\\taesche\\My 
Documents\\modelling\\3D64\\currentvalues125.txt','w'); 
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fprintf (File, 'Model Number\t Current left side (A/m)\t 
Current right side (A/m) \n' ); 
fclose(File); 
 
for g=1:10; 
    model = ModelUtil.create('Model'); 
 
    model.modelPath('C:\Users\taesche\My 
Documents\modelling\3D64'); 
 
    model.modelNode.create('mod1'); 
 
    model.geom.create('geom1', 3); 
 
    model.mesh.create('mesh1', 'geom1'); 
 
    model.physics.create('mef', 
'ElectricInductionCurrents', 'geom1'); 
 
    model.study.create('std1'); 
    model.study('std1').feature.create('freq', 
'Frequency'); 
 
    model.geom('geom1').lengthUnit('mm'); 
%     model.geom('geom1').runAll; 
 
    model.name('katia_3D_one.mph'); 
 
    model.geom('geom1').feature.create('blk1', 'Block'); 
    model.geom('geom1').feature('blk1').set('base', 
'center'); 
    model.geom('geom1').feature('blk1').setIndex('size', 
'5', 0); 
    model.geom('geom1').feature('blk1').setIndex('size', 
'5', 1); 
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    model.geom('geom1').feature('blk1').setIndex('size', 
'5', 2); 
    model.geom('geom1').run('blk1'); 
   
    model.geom('geom1').feature.create('wp1', 'WorkPlane'); 
    
model.geom('geom1').feature('wp1').geom.feature.create('r1'
, 'Rectangle'); 
    
model.geom('geom1').feature('wp1').geom.feature('r1').set('
base', 'corner'); 
    
model.geom('geom1').feature('wp1').geom.feature('r1').set('
pos', {'-6' '-2'}                                            
); 
    
model.geom('geom1').feature('wp1').geom.feature('r1').set('
lx', '3.5'); 
    
model.geom('geom1').feature('wp1').geom.feature('r1').set('
ly', '4.5'); 
    model.geom('geom1').feature('wp1').geom.run('r1'); 
    model.geom('geom1').feature('wp1').set('quickplane', 
'zx'); 
    
model.geom('geom1').feature('wp1').geom.feature('r1').setIn
dex('size', '.5', 0); 
    
model.geom('geom1').feature('wp1').geom.feature('r1').setIn
dex('size', '14.5', 0); 
    
model.geom('geom1').feature('wp1').geom.feature('r1').setIn
dex('size', '7.5', 1); 
    
model.geom('geom1').feature('wp1').geom.feature('r1').setIn
dex('pos', '-17.5', 0); 
    
model.geom('geom1').feature('wp1').geom.feature('r1').setIn
dex('pos', '-2.5', 1); 
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model.geom('geom1').feature('wp1').geom.feature('r1').setIn
dex('size', '5', 1); 
  
   
    model.geom('geom1').feature('wp1').set('quickplane', 
'xz'); 
 
 
    
model.geom('geom1').feature('wp1').geom.feature.create('r2'
, 'Rectangle'); 
    
model.geom('geom1').feature('wp1').geom.feature('r2').set('
base', 'corner'); 
    
model.geom('geom1').feature('wp1').geom.feature('r2').set('
pos', {'-17.5' '2.5'}); 
    
model.geom('geom1').feature('wp1').geom.feature('r2').set('
lx', '12.5'); 
    
model.geom('geom1').feature('wp1').geom.feature('r2').set('
ly', '7.5'); 
    model.geom('geom1').feature('wp1').geom.run('r2'); 
    
model.geom('geom1').feature('wp1').geom.feature('r2').setIn
dex('size', '15', 0); 
    model.geom('geom1').feature('wp1').geom.run('r2'); 
    
model.geom('geom1').feature('wp1').geom.feature.create('r3'
, 'Rectangle'); 
    
model.geom('geom1').feature('wp1').geom.feature('r3').set('
base', 'corner'); 
    
model.geom('geom1').feature('wp1').geom.feature('r3').set('
pos', {'-20' '-10'}); 
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model.geom('geom1').feature('wp1').geom.feature('r3').set('
lx', '17'); 
    
model.geom('geom1').feature('wp1').geom.feature('r3').set('
ly', '7.5'); 
    model.geom('geom1').feature('wp1').geom.run('r3'); 
    
model.geom('geom1').feature('wp1').geom.feature('r3').setIn
dex('pos', '-17.5', 0); 
    model.geom('geom1').feature('wp1').geom.run('r3'); 
    
model.geom('geom1').feature('wp1').geom.feature('r3').setIn
dex('size', '15', 0); 
    model.geom('geom1').feature('wp1').geom.run('r3'); 
    
model.geom('geom1').feature('wp1').geom.feature.create('r4'
, 'Rectangle'); 
    
model.geom('geom1').feature('wp1').geom.feature('r4').set('
base', 'corner'); 
    
model.geom('geom1').feature('wp1').geom.feature('r4').set('
pos', {'-2.5' '2.5'}); 
    
model.geom('geom1').feature('wp1').geom.feature('r4').set('
lx', '7.5'); 
    
model.geom('geom1').feature('wp1').geom.feature('r4').set('
ly', '7.5'); 
    model.geom('geom1').feature('wp1').geom.run('r4'); 
    
model.geom('geom1').feature('wp1').geom.feature('r4').setIn
dex('size', '5', 0); 
    model.geom('geom1').feature('wp1').geom.run('r4'); 
    
model.geom('geom1').feature('wp1').geom.feature.create('r5'
, 'Rectangle'); 
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model.geom('geom1').feature('wp1').geom.feature('r5').set('
base', 'corner'); 
    
model.geom('geom1').feature('wp1').geom.feature('r5').set('
pos', {'-2.5' '-10'}); 
    
model.geom('geom1').feature('wp1').geom.feature('r5').set('
lx', '5'); 
    
model.geom('geom1').feature('wp1').geom.feature('r5').set('
ly', '7.5'); 
    model.geom('geom1').feature('wp1').geom.run('r5'); 
    model.geom('geom1').feature('wp1').geom.run('r5'); 
    
model.geom('geom1').feature('wp1').geom.feature.create('mir
1', 'Mirror'); 
    
model.geom('geom1').feature('wp1').geom.feature('mir1').sel
ection('input').set({'r1' 'r2' 'r3'}); 
    
model.geom('geom1').feature('wp1').geom.feature('mir1').set
('keep', 'on'); 
    model.geom('geom1').feature('wp1').geom.run('mir1'); 
    model.geom('geom1').run('wp1'); 
    model.geom('geom1').run('wp1'); 
    model.geom('geom1').feature.create('ext1', 'Extrude'); 
    
model.geom('geom1').feature('ext1').setIndex('distance', 
'5', 0); 
 
    
model.geom('geom1').feature('ext1').setIndex('distance', 
'2.5', 0); 
    model.geom('geom1').run('ext1'); 
    model.geom('geom1').feature('ext1').set('reverse', 
'on'); 
    model.geom('geom1').run('ext1'); 
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    model.geom('geom1').feature('wp1').set('quicky', '-
2.5'); 
    model.geom('geom1').feature('ext1').set('reverse', 
'off'); 
    
model.geom('geom1').feature('ext1').setIndex('distance', 
'5', 0); 
    model.geom('geom1').run('ext1'); 
    model.geom('geom1').feature('ext1').set('reverse', 
'on'); 
    model.geom('geom1').run('ext1'); 
    model.geom('geom1').run('ext1'); 
    model.geom('geom1').feature.create('wp2', 'WorkPlane'); 
    model.geom('geom1').feature('wp2').set('quickplane', 
'xz'); 
    model.geom('geom1').feature('wp2').set('quicky', '-5'); 
    model.geom('geom1').run('wp2'); 
    
model.geom('geom1').feature('wp2').geom.feature.create('r1'
, 'Rectangle'); 
    
model.geom('geom1').feature('wp2').geom.feature('r1').set('
base', 'corner'); 
    
model.geom('geom1').feature('wp2').geom.feature('r1').set('
pos', {'-17.5' '-10'}); 
    
model.geom('geom1').feature('wp2').geom.feature('r1').set('
lx', '35'); 
    
model.geom('geom1').feature('wp2').geom.feature('r1').set('
ly', '20'); 
    model.geom('geom1').feature('wp2').geom.run('r1'); 
    model.geom('geom1').run('wp2'); 
    model.geom('geom1').feature.create('ext2', 'Extrude'); 
    model.geom('geom1').feature('wp2').set('quicky', '-
17.5'); 
    model.geom('geom1').run('wp2'); 
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model.geom('geom1').feature('ext2').setIndex('distance', 
'15', 0); 
    model.geom('geom1').run('ext2'); 
    model.geom('geom1').feature('ext2').set('reverse', 
'on'); 
    model.geom('geom1').run('ext2'); 
    model.geom('geom1').run('ext2'); 
    model.geom('geom1').feature.create('wp3', 'WorkPlane'); 
    model.geom('geom1').feature('wp3').set('quickplane', 
'xz'); 
    model.geom('geom1').feature('wp3').set('quicky', 
'17.5'); 
    model.geom('geom1').run('wp3'); 
    model.geom('geom1').run('wp3'); 
    model.geom('geom1').feature.create('ext3', 'Extrude'); 
    
model.geom('geom1').feature('ext3').setIndex('distance', 
'15', 0); 
    model.geom('geom1').feature.remove('ext3'); 
    
model.geom('geom1').feature('wp3').geom.feature.create('r1'
, 'Rectangle'); 
    
model.geom('geom1').feature('wp3').geom.feature('r1').set('
base', 'corner'); 
    
model.geom('geom1').feature('wp3').geom.feature('r1').set('
pos', {'-17.5' '-10'}); 
    
model.geom('geom1').feature('wp3').geom.feature('r1').set('
lx', '35'); 
    
model.geom('geom1').feature('wp3').geom.feature('r1').set('
ly', '20'); 
    model.geom('geom1').feature('wp3').geom.run('r1'); 
    model.geom('geom1').run('wp3'); 
    model.geom('geom1').feature.create('ext3', 'Extrude'); 
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model.geom('geom1').feature('ext3').setIndex('distance', 
'15', 0); 
    model.geom('geom1').run('ext3'); 
     
       
     
    a=-length/2; 
    b=length/2; 
 
    k_x=round(n_of_c^(1/3)); 
    k_y=k_x; 
    k_z=round(n_of_c/(k_x*k_y)); 
    n_of_c=k_x*k_y*k_z; 
 
    h_x=(b-a)/k_x; 
    h_y=(b-a)/k_y; 
    h_z=(b-a)/k_z; 
     
    radius= (3*CVIB/(4*n_of_c*pi))^(1/3) 
 
 
 
    num=0; 
    %geometrical_iterations 
    for i=1:k_x; 
        for j=1:k_y; 
            for k=1:k_z; 
                num=num+1; 
 
                name1=sprintf('c%d',num); 
                ebx=a+radius+(i-1)*h_x; 
                eex=ebx+h_x-2*radius; 
                x=ebx+(eex-ebx).*rand; 
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                eby=a+radius+(j-1)*h_y; 
                eey=eby+h_y-2*radius; 
                y=eby+(eey-eby).*rand; 
                ebz=a+radius+(k-1)*h_z; 
                eez=ebz+h_z-2*radius; 
                z=ebz+(eez-ebz).*rand; 
 
                model.geom('geom1').feature.create(name1, 
'Sphere'); 
                model.geom('geom1').feature(name1).set('r', 
sprintf('%f',radius)); 
                
model.geom('geom1').feature(name1).setIndex('pos', 
sprintf('%f',x), 0); 
                
model.geom('geom1').feature(name1).setIndex('pos', 
sprintf('%f',y), 1); 
                
model.geom('geom1').feature(name1).setIndex('pos', 
sprintf('%f',z), 2); 
                model.geom('geom1').run(name1); 
 
                              
                c=sprintf('sphere %d is ok \n',num) 
            end 
         end 
    end  
     
    model.geom('geom1').run; 
 
    model.material.create('mat1'); 
    model.material('mat1').name('blood_base'); 
    model.material('mat1').selection.set([1]); 
    
model.material('mat1').materialModel('def').set('electricco
nductivity', {'1.76'}); 
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model.material('mat1').materialModel('def').set('relpermitt
ivity', {'79'}); 
    
model.material('mat1').materialModel('def').set('relpermeab
ility', {'1'}); 
 
 
    model.material.create('mat2'); 
    model.material('mat2').name('cholesterol'); 
    
model.material('mat2').materialModel('def').set('electricco
nductivity', {'0.025'}); 
    
model.material('mat2').materialModel('def').set('relpermeab
ility', {'1'}); 
    
model.material('mat2').materialModel('def').set('relpermitt
ivity', {'10000'}); 
     
    model.material.create('mat3'); 
    model.material('mat3').name('Air'); 
    
model.material('mat3').materialModel('def').set('relpermeab
ility', '1'); 
    
model.material('mat3').materialModel('def').set('relpermitt
ivity', '1'); 
    
model.material('mat3').materialModel('def').set('electricco
nductivity', '0'); 
 
 
    mat_n=n_of_c+8; 
    mat_n1=n_of_c+9; 
    mat_m=n_of_c+11; 
    model.material('mat2').selection.set([9:mat_n]); 
    model.material('mat1').selection.set([6 7 8]) 
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    model.material('mat3').selection.set([1:5, 
mat_n1:mat_m]); 
 
    c='materials ok' 
     
    model.mesh('mesh1').feature.create('ftet1', 'FreeTet'); 
    model.mesh('mesh1').run; 
     
    model.physics('mef').feature.create('pot1', 
'ElectricPotential', 2); 
    
model.physics('mef').feature('pot1').selection.set([1043 
1044 1045 1048 1051 1053]); 
    model.physics('mef').feature('pot1').set('V0', 1, '-
1.428'); 
     
    model.physics('mef').feature.create('pot2', 
'ElectricPotential', 2); 
    model.physics('mef').feature('pot2').selection.set([22 
23 24 25 26 30]); 
    model.physics('mef').feature('pot2').set('V0', 1, 
'1.428'); 
     
 
    model.study('std1').feature('freq').set('plist', 
'50000'); 
       
    model.name('twelve_spheres.mph'); 
  
    model.view('view1').set('transparency', 'on'); 
      
    model.sol.create('sol1'); 
    model.sol('sol1').feature.create('st1', 'StudyStep'); 
    model.sol('sol1').feature('st1').set('study', 'std1'); 
    model.sol('sol1').feature('st1').set('studystep', 
'freq'); 
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    model.sol('sol1').feature.create('v1', 'Variables'); 
    model.sol('sol1').feature.create('s1', 'Stationary'); 
    model.sol('sol1').feature('s1').set('nonlin', 
'linearized'); 
    model.sol('sol1').feature('s1').feature.create('p1', 
'Parametric'); 
    
model.sol('sol1').feature('s1').feature('p1').set('pname', 
'freq'); 
    
model.sol('sol1').feature('s1').feature('p1').set('plist', 
'50000'); 
    
model.sol('sol1').feature('s1').feature('p1').set('plot', 
'off'); 
    
model.sol('sol1').feature('s1').feature('p1').set('probesel
', 'all'); 
    
model.sol('sol1').feature('s1').feature('p1').set('probes', 
{}); 
    model.sol('sol1').feature('s1').feature.create('fc1', 
'FullyCoupled'); 
    model.sol('sol1').feature('s1').feature.create('i1', 
'Iterative'); 
    
model.sol('sol1').feature('s1').feature('i1').set('linsolve
r', 'gmres'); 
    
model.sol('sol1').feature('s1').feature('fc1').set('linsolv
er', 'i1'); 
    
model.sol('sol1').feature('s1').feature('i1').feature.creat
e('mg1', 'Multigrid'); 
    
model.sol('sol1').feature('s1').feature('i1').feature('mg1'
).feature('pr').feature.create('sv1', 'SORVector'); 
    
model.sol('sol1').feature('s1').feature('i1').feature('mg1'
).feature('pr').feature('sv1').set('prefun', 'sorvec'); 
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model.sol('sol1').feature('s1').feature('i1').feature('mg1'
).feature('po').feature.create('sv1', 'SORVector'); 
    
model.sol('sol1').feature('s1').feature('i1').feature('mg1'
).feature('po').feature('sv1').set('prefun', 'soruvec'); 
    
model.sol('sol1').feature('s1').feature.remove('fcDef'); 
    model.sol('sol1').attach('std1'); 
    model.sol('sol1').feature('v1').set('initmethod', 
'sol'); 
    model.sol('sol1').feature('v1').set('initsol', 'sol1'); 
    model.sol('sol1').feature('v1').set('initmethod', 
'init'); 
    model.sol('sol1').feature('v1').set('initsol', 'zero'); 
    
model.sol('sol1').feature('v1').feature('mod1_A').set('solv
efor', 'off'); 
    
model.sol('sol1').feature('v1').feature('mod1_A').set('out'
, 'off'); 
    model.sol('sol1').feature('s1').set('linpsol', 'sol1'); 
 
    model.result.create('pg1', 3); 
    model.result('pg1').set('data', 'dset1'); 
    model.result('pg1').feature.create('surf1', 'Surface'); 
    model.result.create('pg2', 3); 
    model.result('pg2').set('data', 'dset1'); 
    model.result('pg2').feature.create('slc1', 'Slice'); 
 
    model.sol('sol1').runAll; 
 
    model.result('pg1').run; 
 
    model.result.numerical.create('int1', 'IntSurface'); 
    model.result.numerical('int1').selection.set([30]); 
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    model.result.numerical('int1').set('expr', 
'mef.normJ'); 
    model.result.numerical('int1').set('descr', 'Current 
density norm'); 
    model.result.table.create('tbl1', 'Table'); 
    model.result.table('tbl1').comments('Surface 
Integration 1 (mef.normJ)'); 
    model.result.numerical('int1').set('table', 'tbl1'); 
    model.result.numerical('int1').setResult; 
 
    model.result.numerical.create('int2', 'IntSurface'); 
    model.result.numerical('int2').selection.set([1043]); 
    model.result.numerical('int2').set('expr', 
'mef.normJ'); 
    model.result.numerical('int2').set('descr', 'Current 
density norm'); 
    model.result('pg1').run; 
 
 
    name_f=sprintf('C:\\Users\\taesche\\My 
Documents\\modelling\\3D64\\125_spheres%d.mph',g); 
    model.save(name_f); 
    
    J1 = model.result.numerical('int1').getReal(); 
    J2 = model.result.numerical('int2').getReal(); 
    File = fopen('C:\\Users\\taesche\\My 
Documents\\modelling\\3D64\\currentvalues125.txt','a'); 
    fprintf(File,'%d\t\t%f\t\t%f\t\t| \n', g, J1, J2); 
    fclose(File); 
     
end 
out = model; 
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Appendix 5. MatLab scripts for random 
distribution of RBC and cholesterol particles 
in 3D finite element models  
Main file: 
function out = one_3D  
 
% katia_init.m  
% 
% ==== COPYRIGHT EKATERINA ARISTOVICH ==== 
% 
% Model exported on Jan 31 2011, 22:35 by COMSOL 4.0.0.982. 
 RandStream.setDefaultStream ... 
     (RandStream('mt19937ar','seed',sum(100*clock))); 
 
%Total volume of domain 
Volume = 125; 
%length of the domain - we consider it to be a cube 
length = Volume^(1/3); 
 
% TC – total cholesterol 
TC=5; 
 
%Volume of all RBC in the domain 
CVIB=Volume*0.000525*TC; 
Volume_RBC=Volume*0.0644; 
 
%Number of RBC 
N_RBC=1000; 
 
%Number of cholesterol particles 
N_CHOL=100; 
  
import com.comsol.model.* 
import com.comsol.model.util.* 
File = 
fopen('C:\Users\Katia\Documents\Katya\modelling\3D64\ext_fi
ne\RBC\currentvaluescholrbc.txt','w'); 
fprintf (File, 'Model Number\t Current left side (A/m)\t 
Current right side (A/m) \n' ); 
fclose(File); 
Appendices 
 
176 
 
  
 for g=1:20; 
%  g=0; 
    model = ModelUtil.create('Model'); 
  
    model.modelPath('D:\\Red_Blood_cells'); 
  
    model.modelNode.create('mod1'); 
  
    model.geom.create('geom1', 3); 
  
    model.mesh.create('mesh1', 'geom1'); 
  
    model.physics.create('mef', 
'ElectricInductionCurrents', 'geom1'); 
  
    model.study.create('std1'); 
    model.study('std1').feature.create('freq', 
'Frequency'); 
  
    model.geom('geom1').lengthUnit('mm'); 
 
    model.name('katia_3D_one.mph'); 
  
    model.geom('geom1').feature.create('blk1', 'Block'); 
    model.geom('geom1').feature('blk1').set('base', 
'center'); 
    model.geom('geom1').feature('blk1').setIndex('size', 
'5', 0); 
    model.geom('geom1').feature('blk1').setIndex('size', 
'5', 1); 
    model.geom('geom1').feature('blk1').setIndex('size', 
'5', 2); 
    model.geom('geom1').run('blk1'); 
   
    model.geom('geom1').feature.create('wp1', 'WorkPlane'); 
    
model.geom('geom1').feature('wp1').geom.feature.create('r1'
, 'Rectangle'); 
    
model.geom('geom1').feature('wp1').geom.feature('r1').set('
base', 'corner'); 
    
model.geom('geom1').feature('wp1').geom.feature('r1').set('
pos', {'-6' '-2'}); 
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model.geom('geom1').feature('wp1').geom.feature('r1').set('
lx', '3.5'); 
    
model.geom('geom1').feature('wp1').geom.feature('r1').set('
ly', '4.5'); 
    model.geom('geom1').feature('wp1').geom.run('r1'); 
    model.geom('geom1').feature('wp1').set('quickplane', 
'zx'); 
    
model.geom('geom1').feature('wp1').geom.feature('r1').setIn
dex('size', '.5', 0); 
    
model.geom('geom1').feature('wp1').geom.feature('r1').setIn
dex('size', '14.5', 0); 
    
model.geom('geom1').feature('wp1').geom.feature('r1').setIn
dex('size', '7.5', 1); 
    
model.geom('geom1').feature('wp1').geom.feature('r1').setIn
dex('pos', '-17.5', 0); 
    
model.geom('geom1').feature('wp1').geom.feature('r1').setIn
dex('pos', '-2.5', 1); 
   
    
model.geom('geom1').feature('wp1').geom.feature('r1').setIn
dex('size', '5', 1); 
  
   
    model.geom('geom1').feature('wp1').set('quickplane', 
'xz'); 
  
  
    
model.geom('geom1').feature('wp1').geom.feature.create('r2'
, 'Rectangle'); 
    
model.geom('geom1').feature('wp1').geom.feature('r2').set('
base', 'corner'); 
    
model.geom('geom1').feature('wp1').geom.feature('r2').set('
pos', {'-17.5' '2.5'}); 
    
model.geom('geom1').feature('wp1').geom.feature('r2').set('
lx', '12.5'); 
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model.geom('geom1').feature('wp1').geom.feature('r2').set('
ly', '7.5'); 
    model.geom('geom1').feature('wp1').geom.run('r2'); 
    
model.geom('geom1').feature('wp1').geom.feature('r2').setIn
dex('size', '15', 0); 
    model.geom('geom1').feature('wp1').geom.run('r2'); 
    
model.geom('geom1').feature('wp1').geom.feature.create('r3'
, 'Rectangle'); 
    
model.geom('geom1').feature('wp1').geom.feature('r3').set('
base', 'corner'); 
    
model.geom('geom1').feature('wp1').geom.feature('r3').set('
pos', {'-20' '-10'}); 
    
model.geom('geom1').feature('wp1').geom.feature('r3').set('
lx', '17'); 
    
model.geom('geom1').feature('wp1').geom.feature('r3').set('
ly', '7.5'); 
    model.geom('geom1').feature('wp1').geom.run('r3'); 
    
model.geom('geom1').feature('wp1').geom.feature('r3').setIn
dex('pos', '-17.5', 0); 
    model.geom('geom1').feature('wp1').geom.run('r3'); 
    
model.geom('geom1').feature('wp1').geom.feature('r3').setIn
dex('size', '15', 0); 
    model.geom('geom1').feature('wp1').geom.run('r3'); 
    
model.geom('geom1').feature('wp1').geom.feature.create('r4'
, 'Rectangle'); 
    
model.geom('geom1').feature('wp1').geom.feature('r4').set('
base', 'corner'); 
    
model.geom('geom1').feature('wp1').geom.feature('r4').set('
pos', {'-2.5' '2.5'}); 
    
model.geom('geom1').feature('wp1').geom.feature('r4').set('
lx', '7.5'); 
    
model.geom('geom1').feature('wp1').geom.feature('r4').set('
ly', '7.5'); 
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    model.geom('geom1').feature('wp1').geom.run('r4'); 
    
model.geom('geom1').feature('wp1').geom.feature('r4').setIn
dex('size', '5', 0); 
    model.geom('geom1').feature('wp1').geom.run('r4'); 
    
model.geom('geom1').feature('wp1').geom.feature.create('r5'
, 'Rectangle'); 
    
model.geom('geom1').feature('wp1').geom.feature('r5').set('
base', 'corner'); 
    
model.geom('geom1').feature('wp1').geom.feature('r5').set('
pos', {'-2.5' '-10'}); 
    
model.geom('geom1').feature('wp1').geom.feature('r5').set('
lx', '5'); 
    
model.geom('geom1').feature('wp1').geom.feature('r5').set('
ly', '7.5'); 
    model.geom('geom1').feature('wp1').geom.run('r5'); 
    model.geom('geom1').feature('wp1').geom.run('r5'); 
    
model.geom('geom1').feature('wp1').geom.feature.create('mir
1', 'Mirror'); 
    
model.geom('geom1').feature('wp1').geom.feature('mir1').sel
ection('input').set({'r1' 'r2' 'r3'}); 
    
model.geom('geom1').feature('wp1').geom.feature('mir1').set
('keep', 'on'); 
    model.geom('geom1').feature('wp1').geom.run('mir1'); 
    model.geom('geom1').run('wp1'); 
%    model.geom('geom1').run('wp1'); 
    model.geom('geom1').feature.create('ext1', 'Extrude'); 
    
model.geom('geom1').feature('ext1').setIndex('distance', 
'5', 0); 
  
    
model.geom('geom1').feature('ext1').setIndex('distance', 
'2.5', 0); 
    model.geom('geom1').run('ext1'); 
    model.geom('geom1').feature('ext1').set('reverse', 
'on'); 
    model.geom('geom1').run('ext1'); 
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    model.geom('geom1').feature('wp1').set('quicky', '-
2.5'); 
    model.geom('geom1').feature('ext1').set('reverse', 
'off'); 
    
model.geom('geom1').feature('ext1').setIndex('distance', 
'5', 0); 
    model.geom('geom1').run('ext1'); 
    model.geom('geom1').feature('ext1').set('reverse', 
'on'); 
    model.geom('geom1').run('ext1'); 
    model.geom('geom1').run('ext1'); 
    model.geom('geom1').feature.create('wp2', 'WorkPlane'); 
    model.geom('geom1').feature('wp2').set('quickplane', 
'xz'); 
    model.geom('geom1').feature('wp2').set('quicky', '-5'); 
    model.geom('geom1').run('wp2'); 
    
model.geom('geom1').feature('wp2').geom.feature.create('r1'
, 'Rectangle'); 
    
model.geom('geom1').feature('wp2').geom.feature('r1').set('
base', 'corner'); 
    
model.geom('geom1').feature('wp2').geom.feature('r1').set('
pos', {'-17.5' '-10'}); 
    
model.geom('geom1').feature('wp2').geom.feature('r1').set('
lx', '35'); 
    
model.geom('geom1').feature('wp2').geom.feature('r1').set('
ly', '20'); 
    model.geom('geom1').feature('wp2').geom.run('r1'); 
    model.geom('geom1').run('wp2'); 
    model.geom('geom1').feature.create('ext2', 'Extrude'); 
    model.geom('geom1').feature('wp2').set('quicky', '-
17.5'); 
    model.geom('geom1').run('wp2'); 
    
model.geom('geom1').feature('ext2').setIndex('distance', 
'15', 0); 
    model.geom('geom1').run('ext2'); 
    model.geom('geom1').feature('ext2').set('reverse', 
'on'); 
    model.geom('geom1').run('ext2'); 
    model.geom('geom1').run('ext2'); 
    model.geom('geom1').feature.create('wp3', 'WorkPlane'); 
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    model.geom('geom1').feature('wp3').set('quickplane', 
'xz'); 
    model.geom('geom1').feature('wp3').set('quicky', 
'17.5'); 
    model.geom('geom1').run('wp3'); 
    model.geom('geom1').run('wp3'); 
    model.geom('geom1').feature.create('ext3', 'Extrude'); 
    
model.geom('geom1').feature('ext3').setIndex('distance', 
'15', 0); 
    model.geom('geom1').feature.remove('ext3'); 
    
model.geom('geom1').feature('wp3').geom.feature.create('r1'
, 'Rectangle'); 
    
model.geom('geom1').feature('wp3').geom.feature('r1').set('
base', 'corner'); 
    
model.geom('geom1').feature('wp3').geom.feature('r1').set('
pos', {'-17.5' '-10'}); 
    
model.geom('geom1').feature('wp3').geom.feature('r1').set('
lx', '35'); 
    
model.geom('geom1').feature('wp3').geom.feature('r1').set('
ly', '20'); 
    model.geom('geom1').feature('wp3').geom.run('r1'); 
    model.geom('geom1').run('wp3'); 
    model.geom('geom1').feature.create('ext3', 'Extrude'); 
    
model.geom('geom1').feature('ext3').setIndex('distance', 
'15', 0); 
    model.geom('geom1').run('ext3'); 
%    model.geom('geom1').runAll; 
  
 %   model.geom('geom1').run;   
%----------------------------------------------------------
--------------- 
% RED BLOOD CELLS 
% recalculate volume 
     
     k_y_r=round(N_RBC^(1/3)/1.8); 
     k_z_r=k_y_r; 
     k_x_r=round(N_RBC/(k_y_r*k_z_r)); 
     N_RBC=k_x_r*k_y_r*k_z_r; 
     R_RBC=(Volume_RBC*2.27/(N_RBC*pi))^(1/3); 
     h_RBC=R_RBC/2.27; 
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     eps=R_RBC/40; 
     a=eps-length/2; 
     b=-eps+length/2; 
 
     h_x_r=(b-a)/k_x_r ; 
     h_y_r=(b-a)/k_y_r ; 
     h_z_r=(b-a)/k_z_r ; 
     
     clear coord_rbc; 
     num=0; 
     for i=1:k_x_r; 
         for j=1:k_y_r; 
             for k=1:k_z_r; 
                num=num+1; 
  
% for rand RBC orientation 
                 
%                 p=rand; 
%                 for ll=1:3 
%                     if p<0.5  
%                         t(ll)=-1; 
%                     else t(ll)=1; 
%                     end 
%                 end 
                dir_x=1;%t(1)*rand; 
                dir_y=0;%t(2)*rand; 
                dir_z=0;%t(3)*rand; 
                 
                name1=sprintf('rbc%d',num); 
                ebx=a+(i-1)*h_x_r+eps;  
                x=ebx; 
                eby=a+R_RBC+(j-1)*h_y_r+eps;  
                eey=eby+h_y_r-2*R_RBC-2*eps;%*abs(dir_y); 
                y=eby+(eey-eby).*rand; 
                ebz=a+R_RBC+(k-1)*h_z_r+eps; 
                eez=ebz+h_z_r-2*R_RBC-2*eps;%*abs(dir_y); 
                z=ebz+(eez-ebz).*rand; 
     
                coord_rbc(num,1)=x; 
                coord_rbc(num,2)=y; 
                coord_rbc(num,3)=z; 
                    
model.geom('geom1').feature.create(name1, 'Cylinder'); 
                    
model.geom('geom1').feature(name1).set('r',sprintf('%f',R_R
BC) ); 
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model.geom('geom1').feature(name1).set('h',sprintf('%f',h_R
BC) ); 
                    
model.geom('geom1').feature(name1).setIndex('pos', 
sprintf('%f',x), 0); 
                    
model.geom('geom1').feature(name1).setIndex('pos', 
sprintf('%f',y), 1); 
                    
model.geom('geom1').feature(name1).setIndex('pos', 
sprintf('%f',z), 2); 
                    
model.geom('geom1').feature(name1).setIndex('ax3', 
sprintf('%f',dir_x), 0); 
                    
model.geom('geom1').feature(name1).setIndex('ax3', 
sprintf('%f',dir_y), 1); 
                    
model.geom('geom1').feature(name1).setIndex('ax3', 
sprintf('%f',dir_z), 2); 
                    
model.geom('geom1').feature(name1).set('rot', '0'); 
                  %  model.geom('geom1').run(name1); 
   end 
  end 
 end 
                     
% for cholesterol 
 
     radius= (3*CVIB/(4*N_CHOL*pi))^(1/3); 
        
    
     coord_chol=[]; 
      
     for i=1:N_CHOL 
         is_on=1; 
         while(is_on) 
             x=a+radius+(b-a-2*radius)*rand; 
             y=a+radius+(b-a-2*radius)*rand; 
             z=a+radius+(b-a-2*radius)*rand; 
              
             is_on=0; 
             for j=1:N_RBC 
                 if (1.6*(x-coord_rbc(j,1))^2+0.9*(y-
coord_rbc(j,2))^2+0.9*(z-
coord_rbc(j,3))^2<=(R_RBC+radius)^2) 
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                     is_on=1; 
                     break; 
                 end 
             end 
              
             if(i>1) 
             for j=1:i-1 
                 if ((x-coord_chol(j,1))^2+(y-
coord_chol(j,2))^2+(z-coord_chol(j,3))^2<=(2*radius)^2) 
                     is_on=1; 
                     break; 
                 end 
             end 
             end 
         end 
          
         coord_chol(i,1)=x; 
         coord_chol(i,2)=y; 
         coord_chol(i,3)=z; 
          
        name1=sprintf('colest%d',i); 
%            c=sprintf('making %d',k) 
           model.geom('geom1').feature.create(name1, 
'Sphere'); 
           model.geom('geom1').feature(name1).set('r', 
sprintf('%f',radius)); 
           
model.geom('geom1').feature(name1).setIndex('pos', 
sprintf('%f',x), 0); 
           
model.geom('geom1').feature(name1).setIndex('pos', 
sprintf('%f',y), 1); 
           
model.geom('geom1').feature(name1).setIndex('pos', 
sprintf('%f',z), 2);  
     end   
    %model.geom('geom1').runAll; 
    model.geom('geom1').run; 
    
name_f=sprintf('C:\\Users\\Katia\\Documents\\Katya\\modelli
ng\\3D64\\ext_fine\\RBC\\Parallel_RBCyz_%d_%d_%d.mph',N_RBC
,N_CHOL,g); 
    model.save(name_f); 
     
     
   
   try  
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            model.geom('geom1').run; 
  
            model.material.create('mat1'); 
            model.material('mat1').name('blood_base'); 
            
model.material('mat1').materialModel('def').set('electricco
nductivity', {'1.76'}); 
            
model.material('mat1').materialModel('def').set('relpermitt
ivity', {'79'}); 
            
model.material('mat1').materialModel('def').set('relpermeab
ility', {'1'}); 
  
  
            model.material.create('mat2'); 
            model.material('mat2').name('cholesterol'); 
            
model.material('mat2').materialModel('def').set('electricco
nductivity', {'0.025'}); 
            
model.material('mat2').materialModel('def').set('relpermeab
ility', {'1'}); 
            
model.material('mat2').materialModel('def').set('relpermitt
ivity', {'10000'}); 
  
            model.material.create('mat3'); 
            model.material('mat3').name('Air'); 
            
model.material('mat3').materialModel('def').set('relpermeab
ility', '1'); 
            
model.material('mat3').materialModel('def').set('relpermitt
ivity', '1'); 
            
model.material('mat3').materialModel('def').set('electricco
nductivity', '0'); 
             
            model.material.create('mat4'); 
            model.material('mat4').name('RBC'); 
            
model.material('mat4').materialModel('def').set('electricco
nductivity', {'0.7'}); 
            
model.material('mat4').materialModel('def').set('relpermitt
ivity', {'79'}); 
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model.material('mat4').materialModel('def').set('relpermeab
ility', {'1'}); 
  
  
%!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! 
      
            domains = Get_Domains(model.geom('geom1')); 
           % domains = model.geom('geom1').objectNames(); 
            domains = char(domains); 
  
            ind_colest=find (domains(:,1)=='c'& 
domains(:,2)=='o')'; 
            ind_RBC = find (domains(:,1)=='r'& 
domains(:,2)=='b')'; 
            ind_air = [1:5,(size(domains,1)-
2):size(domains,1)]; 
            not_BB = [ind_colest,ind_RBC,ind_air]; 
            BB= find(~ismember([1:size(domains)],not_BB)); 
             
            model.material('mat4').selection.set(ind_RBC); 
            
model.material('mat2').selection.set(ind_colest); 
            model.material('mat3').selection.set(ind_air); 
            model.material('mat1').selection.set(BB); 
             
            
            c='materials ok' 
             
            model.save(name_f); 
             
             
            model.physics('mef').feature.create('pot1', 
'ElectricPotential', 2); 
            sel=mphselectbox(model,'geom1', [-3.0001,-2.5,-
2.5 ; -2.4999,2.5,2.5]','boundary'); 
            
model.physics('mef').feature('pot1').selection.set(sel); 
            model.physics('mef').feature('pot1').set('V0', 
1, '-1.428'); 
  
            model.physics('mef').feature.create('pot2', 
'ElectricPotential', 2); 
            sel=mphselectbox(model,'geom1', [3.0001,-2.5,-
2.5 ; 2.4999,2.5,2.5]','boundary'); 
            
model.physics('mef').feature('pot2').selection.set(sel); 
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            model.physics('mef').feature('pot2').set('V0', 
1, '1.428');  
            model.save(name_f); 
            c='boundaries ok' 
% %!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! 
             model.mesh('mesh1').feature.create('ftet1', 
'FreeTet'); 
              
             
model.mesh('mesh1').feature('size').set('hauto', '2'); 
             model.mesh('mesh1').run; 
             c='mesh ok' 
             model.save(name_f); 
              
             
              
             
model.study('std1').feature('freq').set('plist', '50000'); 
  
             model.name('twelve_spheres.mph'); 
  
             model.view('view1').set('transparency', 'on'); 
  
             model.sol.create('sol1'); 
             model.sol('sol1').feature.create('st1', 
'StudyStep'); 
             model.sol('sol1').feature('st1').set('study', 
'std1'); 
             
model.sol('sol1').feature('st1').set('studystep', 'freq'); 
             model.sol('sol1').feature.create('v1', 
'Variables'); 
             model.sol('sol1').feature.create('s1', 
'Stationary'); 
             model.sol('sol1').feature('s1').set('nonlin', 
'linearized'); 
             
model.sol('sol1').feature('s1').feature.create('p1', 
'Parametric'); 
             
model.sol('sol1').feature('s1').feature('p1').set('pname', 
'freq'); 
             
model.sol('sol1').feature('s1').feature('p1').set('plist', 
'50000'); 
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model.sol('sol1').feature('s1').feature('p1').set('plot', 
'off'); 
             
model.sol('sol1').feature('s1').feature('p1').set('probesel
', 'all'); 
             
model.sol('sol1').feature('s1').feature('p1').set('probes', 
{}); 
             
model.sol('sol1').feature('s1').feature.create('fc1', 
'FullyCoupled'); 
             
model.sol('sol1').feature('s1').feature.create('i1', 
'Iterative'); 
             
model.sol('sol1').feature('s1').feature('i1').set('linsolve
r', 'gmres'); 
             
model.sol('sol1').feature('s1').feature('fc1').set('linsolv
er', 'i1'); 
             
model.sol('sol1').feature('s1').feature('i1').feature.creat
e('mg1', 'Multigrid'); 
             
model.sol('sol1').feature('s1').feature('i1').feature('mg1'
).feature('pr').feature.create('sv1', 'SORVector'); 
             
model.sol('sol1').feature('s1').feature('i1').feature('mg1'
).feature('pr').feature('sv1').set('prefun', 'sorvec'); 
             
model.sol('sol1').feature('s1').feature('i1').feature('mg1'
).feature('po').feature.create('sv1', 'SORVector'); 
             
model.sol('sol1').feature('s1').feature('i1').feature('mg1'
).feature('po').feature('sv1').set('prefun', 'soruvec'); 
             
model.sol('sol1').feature('s1').feature.remove('fcDef'); 
             model.sol('sol1').attach('std1'); 
             
model.sol('sol1').feature('v1').set('initmethod', 'sol'); 
             model.sol('sol1').feature('v1').set('initsol', 
'sol1'); 
             
model.sol('sol1').feature('v1').set('initmethod', 'init'); 
             model.sol('sol1').feature('v1').set('initsol', 
'zero'); 
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model.sol('sol1').feature('v1').feature('mod1_A').set('solv
efor', 'off'); 
             
model.sol('sol1').feature('v1').feature('mod1_A').set('out'
, 'off'); 
             model.sol('sol1').feature('s1').set('linpsol', 
'sol1'); 
  
             model.result.create('pg1', 3); 
             model.result('pg1').set('data', 'dset1'); 
             model.result('pg1').feature.create('surf1', 
'Surface'); 
             model.result.create('pg2', 3); 
             model.result('pg2').set('data', 'dset1'); 
             model.result('pg2').feature.create('slc1', 
'Slice'); 
  
             model.sol('sol1').runAll; 
  
             model.result('pg1').run; 
  
             model.result.numerical.create('int1', 
'IntSurface'); 
             
model.result.numerical('int1').selection.set([30]); 
             model.result.numerical('int1').set('expr', 
'mef.normJ'); 
             model.result.numerical('int1').set('descr', 
'Current density norm'); 
             model.result.table.create('tbl1', 'Table'); 
             model.result.table('tbl1').comments('Surface 
Integration 1 (mef.normJ)'); 
             model.result.numerical('int1').set('table', 
'tbl1'); 
             model.result.numerical('int1').setResult; 
  
             model.result.numerical.create('int2', 
'IntSurface'); 
             
model.result.numerical('int2').selection.set([2787]); 
             model.result.numerical('int2').set('expr', 
'mef.normJ'); 
             model.result.numerical('int2').set('descr', 
'Current density norm'); 
             model.result('pg1').run; 
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%name_f=sprintf('C:\\Users\\Katia\\Documents\\Katya\\modell
ing\\3D64\\ext_fine\\RBC\\Parallel_RBCyz_%d_%d_%d.mph',N_RB
C,N_CHOL,g); 
             model.save(name_f); 
  
             J1 = model.result.numerical('int1').getReal(); 
             J2 = model.result.numerical('int2').getReal(); 
             File = 
fopen('C:\\Users\\Katia\\Documents\\Katya\\modelling\\3D64\
\ext_fine\\RBC\\currentvalues343.txt','a'); 
             fprintf(File,'%d\t\t%f\t\t%f\t\t| \n', g, J1, 
J2); 
             fclose(File); 
     
     catch exception 
         c=sprintf('file %d is failed to compute! \n',g) 
     end 
end 
out = model; 
 
